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Abstract  
This dissertation focused on the biological activity screening of several Plectranthus spp. 
plants, aiming to unravell novel ethnopharmacological roles and further research, of several 
extracts (methanol, ethyl acetate, acetone and water) and isolated compounds. Previous 
evidences on interesting biological activities of Plectranthus spp. constituents, directed the 
study for antioxidant, anti-skin ageing, anti-inflammatory, and anti-mycobacterial activities. 
Antioxidant results revealed an increased activity of the methanol extracts (20-76%), due 
to the presence of polyphenols widely known as antioxidants. Moreover, P. grandidentatus 
(62.3 ± 0.43%) and P. ecklonii (55.5 ± 1.66%) registered a high scavenging activity in the ethyl 
acetate extract, in comparison with quercetin (89.0 ± 2.5%), most likely due to the presence of 
abietane diterpenes.  
Acetylcholinesterase (AChE) was studied in vitro to evaluate the enzymatic inhibition, 
due to recent discoveries on non-neuronal cholinergic system in the skin. This assay showed 
that the Plectranthus spp. organic extracts did not significantly inhibited AChE.  
Concerning the tyrosinase inhibition assay, it was observed a high inhibition for the P. 
ecklonii methanol (65.9 ± 3.42%), P. grandidentatus acetone (67.9 ± 3.55%), and P. saccatus 
acetone (56.5 ± 5.68%) organic extracts. On the other hand, the aqueous extract of P. porcatus 
was the only one that showed enzymatic inhibition (65.0 ± 8.67%). From the tested isolated 
compounds, abietane diterpenes, mainly present in the organic extracts of P. grandidentatus, 
P. madagascariensis, and P. ecklonii were highly active against tyrosinase, in more than 46% 
and up to 75%, especially compared to kojic acid (92.9 ± 7.28%). 
In the collagenase assay, all tested extracts and compounds showed a high enzymatic 
inhibition which was in the range of 28-76%. The higher inhibition results were obtained from 
P. neochilus methanol extract (76.4 ± 2.09%), P. ecklonii aqueous extract inhibited (75.59 ± 
6.5%) and rosmarinic acid (44.78 ± 4.53%), in comparison with epigallocatechin gallate (93.1 
± 5.27%).  
In contrast to the results of the previous enzymatic assays, the anti-elastase assay 
revealed that in general the extracts did not decrease elastase activity (30-42%). Nonetheless, 
the isolated compounds were tested, and they were able to highly inhibit elastase activity. 
Particularly, the oleanolic:ursolic acids mixture (1:4) with 63.4 ± 2.56% and Parvifloron D with 
52.8 ± 3.76%, were the most efficient in elastase inhibition specially compared with ursolic acid 
used as positive control (69.9 ± 3.65%). 
The anti-inflammatory assay was performed by the quantification of NO production 
using the Griess reaction. The non-cytotoxic isolated compounds revealed to be unable to 
reduce NO production, after LPS stimulated inflammation (ranging from 16-23 µM), in 
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comparison with the normal quantities of NO production within the cells (17.7 ± 0.67 µM), and 
with the positive control L-NAME that decreased NO until reaching 3.9 ± 0.24 µM.  
Finally, the preliminary results of Mycobacterium tuberculosis H37Rv growth assay, 
revealed low CFU/mL (dilution 10-3) especially regarding one halimane diterpene compound 
(2.1×105 CFU/mL), similar to the positive controls isoniazid (1.2×105 CFU/mL), and ethambutol 
(2.0×105 CFU/mL), suggesting a potential alternative for further anti-tubercular studies. 
Overall, according to the references of this study, this was the first report on 
Plectranthus spp., concerning the assays of skin-related enzymatic inhibition in vitro, anti-
inflammatory assay, and Mycobacterium tuberculosis H37Rv growth, with a preliminary 
scientific validation upon known ethnopharmacological uses. 
 
KEYWORDS: Plectranthus spp.; Anti-inflammatory; Antioxidant; Skin enzymatic 
inhibition; Mycobacterium tuberculosis. 
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Resumo 
 
As plantas do género Plectranthus L’Héritier (família Lamiaceae) são selecionadas em 
várias investigações científicas devido aos vários usos etnofarmacológicos pelas populações 
indígenas, e facilidade de crescimento em zonas temperadas. Estas plantas são compostas 
por cerca de 350 espécies reconhecidas pelos seus óleos essenciais e compostos terpénicos.  
Nesta dissertação pretendeu-se desenvolver e complementar o screening de várias 
atividades biológicas, a partir de extratos e compostos isolados de sete espécies de 
Plectranthus (P. grandidentatus Gürke, P. ecklonii Benth., P. ornatus Codd., P. 
madagascariensis (Pers.) Benth., P. porcatus van Jaarsv. & P.J.D.Winter, P. neochilus Schltr., 
e P. prostratus Gürke). Estes estudos biológicos envolveram a pesquisa de atividades 
antioxidante, anti-envelhecimento da pele, anti-inflamatória e anti-micobacteriana.  
Foram obtidos vinte e oito extratos (sete aquosos e vinte e um orgânicos, nomeadamente 
de acetona, metanol e acetato de etilo) de todas as plantas em estudo, obtendo-se os resíduos 
secos (mg de extrato/g de planta).   
Nos resultados preliminares da atividade antioxidante executada pelo método da 
recaptação do radical DPPH, verificou-se que os extratos de metanol detiveram os valores 
mais elevados de recaptação de radicais livres (20-76%), e, portanto, de maior atividade 
antioxidante. Concluiu-se que esta atividade poderá estar relacionada com as elevadas 
quantidades em polifenóis nos extratos metanólicos, amplamente citados como antioxidantes. 
Adicionalmente, foi também registada uma elevada atividade antioxidante para os extratos de 
acetato de etilo de P. ecklonii (55.5 ± 1.66%) e P. grandidentatus (62.3 ± 0.43%), muito 
provavelmente devido à presença de diterpenos abietânicos. Na verdade, estes foram os 
resultados que demonstraram maior atividade antioxidante comparável ao controlo positivo 
usado, quercetina (89.0 ± 2.5%). 
A acetilcolinesterase (AChE, EC 3.1.17), conhecida pela sua ação na terminação do 
impulso nervoso pela hidrólise da acetilcolina, produzindo colina, foi estudada in vitro usando 
o método de Ellman, de modo a avaliar a inibição enzimática pelos extratos e/ou compostos 
isolados. Este ensaio foi realizado com base nos dados recentes da literatura, evidenciando 
um sistema colinérgico não-neuronal pela presença de acetilcolina na pele (humana). Com 
base nos resultados obtidos, foi possível concluir que nenhum dos vinte e um extratos 
orgânicos estudados inibiram a AChE no ensaio enzimático in vitro. 
Relativamente aos ensaios in vitro de inibição enzimática relacionada com a pele, o ensaio 
de inibição da tirosinase (EC 1.14.18.1), uma monooxigenase de cobre que catalisa a síntese 
de melanina pela produção de L-DOPA a partir de L-tirosina, revelou que os extratos orgânicos 
de P. ecklonii metanol (65.9 ± 3.42%), P. grandidentatus acetona (67.9 ± 3.55%), e P. saccatus 
acetona (56.5 ± 5.68%), diminuíram significativamente a atividade enzimática da tirosinase. 
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Por outro lado, o extrato aquoso de P. porcatus foi o único a exibir inibição enzimática da 
tirosinase (65.0 ± 8.67%). De modo a confirmar a atividade registada para os extratos, foram 
testados os compostos isolados. De facto, os compostos abietânicos (maioritariamente 
presentes nos extratos orgânicos de P. grandidentatus, P. madagascariensis, e P. ecklonii) 
demonstraram forte atividade contra a tirosinase, em mais de 46% e até 75%, especialmente 
em comparação com o ácido kójico (92.9 ± 7.28%). 
Relativamente ao ensaio enzimático de inibição da colagenase (EC 3.4.24.3, 
metaloproteinase envolvida na clivagem do colagénio), todas as amostras inibiram, de um 
modo geral, a atividade enzimática (28-76%). Na verdade, o extrato metanólico de P. 
neochilus inibiu a colagenase em 76.4 ± 2.09%, bem como o extrato aquoso de P. ecklonii 
(75.6 ± 6.5%) e o composto ácido rosmarínico em 44.78 ± 4.53%. Estes resultados 
preliminares sugerem que a presença de compostos polifenólicos e diterpenos abietânicos 
nos extratos de Plectranthus, têm uma elevada eficiência inibitória da colagenase semelhante 
à epigallocatequina galhato (93.1 ± 5.27%).  
Em contraste com o que foi obtido nos ensaios enzimáticos da tirosinase e da colagenase, 
no ensaio enzimático de inibição da elastase (EC 3.4.21.36, protease de serina envolvida na 
quebra da elastina) não foi observada a diminuição da atividade enzimática após tratamento 
com os vinte e oito extratos de Plectranthus (30-42% de inibição enzimática). No entanto, os 
compostos isolados testados demonstraram uma elevada inibição. Particularmente, esta ação 
foi observada para a mistura de ácidos oleanólico:ursólico 1:4 (63.4 ± 2.56%) e para a 
Parviflorona D (52.8 ± 3.76%), em comparação com o ácido ursólico usado como controlo 
positivo (69.9 ± 3.65%).  
De um modo geral, os extratos e/ou compostos isolados das sete espécies de 
Plectranthus, revelaram uma elevada capacidade, como redutores da híper pigmentação da 
pele (provocada pela atividade excessiva da tirosinase), e na manutenção da integridade 
dérmica, através da manutenção de colagénio e elastina, pela inibição da colagenase e da 
elastase. Assim, em conjunto com a atividade antioxidante contra a produção de ROS, e na 
inibição de enzimas relacionadas com a integridade dérmica e pigmentação, será possível o 
desenvolvimento de uma aplicação cosmética em ensaios futuros. 
Por outro lado, a capacidade anti-inflamatória dos compostos foi avaliada através da 
inibição da produção de NO, usando a reação de Griess. Assim, após a avaliação da 
citotoxicidade dos compostos testados (em várias concentrações) através do ensaio MTT, foi 
medida a inflamação em células de macrófagos RAW 264.7. Após estimulação da inflamação 
celular com LPS, e tratamento com os compostos não tóxicos, este ensaio revelou que os 
compostos testados não foram capazes de reduzir a produção de NO (16-23 µM), em 
comparação com a quantidade de NO produzida naturalmente pelas células (17.7 ± 0.67 µM) 
e com o L-NAME, usado como controlo positivo (3.9 ± 0.2 µM). Uma vez que a inflamação 
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não é apenas proporcional à produção de NO, mas também de outros mediadores 
inflamatórios, será necessário expandir a investigação desta atividade biológica. De modo a 
compreender, se de facto, os compostos isolados de Plectranthus são anti-inflamatórios por 
outros mecanismos, como por exemplo, por inibição enzimática da ciclooxigenase-2 (COX-2).  
Finalmente, foi avaliado o crescimento de Mycobacterium tuberculosis (Mtb) H37Rv após 
a infeção de macrófagos, derivados de células mononucleares do sangue periférico (PBMC). 
Numa primeira abordagem, o crescimento bacteriano foi monitorizado pela contagem de 
unidades formadoras de colónias (UFC), nas primeiras horas de infeção, e 13 dias após 
infeção e tratamento com os compostos selecionados. Após a normalização dos valores de 
UFC/mL, os resultados revelaram uma diminuição substancial de colónias de Mtb (na diluição 
10-3), apenas após o tratamento com um composto halimano obtido por hemi-síntese (2.1×105 
UFC/mL).  
Este resultado foi muito semelhante ao dos controlos positivos aplicados, isoniazida 
(1.2×105 UFC/mL) e etambutol (2.0×105 UFC/mL), sugerindo a possível aplicabilidade deste 
tipo de compostos em estudos futuros de terapia anti-tuberculose. Dado o resultado deste 
halimano na notável diminuição de colónias de Mtb, será relevante prosseguir na possível 
avaliação do mecanismo de ação que conduziu à inibição do crescimento bacteriano. Para 
tal, poder-se-ão aplicar técnicas de Western blot e imunofluorescência usando marcadores de 
autofagia, e avaliar a biogénese do fagolisossoma pelos macrófagos infetados. 
No geral, de acordo com as referências consultadas, são aqui reportados os primeiros 
estudos em ensaios de inibição de enzimas relacionadas com a pele, na atividade anti-
inflamatória por via do NO, e na atividade anti-tuberculose de extratos e compostos isolados 
de Plectranthus. Os resultados obtidos nesta dissertação fornecem uma validação científica 
preliminar, sobre os usos amplamente conhecidos e reportados, por estas plantas medicinais. 
Na verdade, são necessários mais estudos na pesquisa de novos alvos terapêuticos mais 
específicos e com menos efeitos adversos, a partir das atividades etnofarmacológicas de 
Plectranthus reportadas até agora. Assim como validações científicas no uso de produtos à 
base de plantas usados no tratamento, cura e prevenção de doenças.  
Uma vez que os produtos naturais representam uma fonte única de compostos protótipo 
no desenvolvimento de novos fármacos, os metabolitos secundários isolados de Plectranthus 
revelam neste estudo, o seu potencial no design de novos medicamentos.   
 
PALAVRAS-CHAVE: Plectranthus spp.; Anti-inflamatório; Antioxidante; Inibição enzimas 
da pele; Mycobacterium tuberculosis. 
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I.1 Overview of natural products from medicinal plants  
Natural products from medicinal plants have been used by indigenous populations for 
thousands of years, as traditional medicines, remedies, potions, and oils for the treatment of 
many ailments (Rijo et al., 2014a; Dias et al., 2012). For their vast ethnomedicinal and 
ethnopharmacological applications which inspired current research in drug discovery, natural 
products provide new and important leads against various pharmacological targets (Butler, 
2004; Dias et al., 2012). In addition, it is well known that many of the drugs in the market have 
been developed from natural products (Rijo et al., 2013a; Pereira et al., 2015; Balunas and 
Kinghorn, 2005).  
The 20th century was known for the intensive search for new compounds using chemical 
synthesis from most of multinational pharmaceutical companies. Natural products operations 
were dismissed or scaled down, despite the significant number of natural product-derived 
drugs, that reached phase III clinical trials (Butler, 2004; Dias et al., 2012; Mishra and Tiwari, 
2011). However, the chemical synthesis approach did not fulfill the high expectations 
concerning the discovery of new lead alternatives, thus there has been a renewed interest on 
natural products, regarding their unique structural diversity (Butler, 2004; Cragg et al., 2008; 
Dias et al., 2012; Mishra and Tiwari, 2011; Rey-Ladino et al., 2011). 
The most ancient records of natural products go back to the “Ebers Papyrus” dated 2900 
B.C., the “Chinese Planta Medica” from 1100 B.C., and “Ayurveda Pharmacopoeia” from India 
more than 5000 years ago (Cragg and Newman, 2013; Samuelsson and Bohlin, 2010). The 
first was an Egyptian pharmaceutical document recording over 700 plants many still used 
today to alleviate cough, inflammation, and colds. These plants were to be used as gargles, 
infusions, ointments, and even pills. The second, documented over 100,000 prescriptions, 
plants practice, raw material, and most are still used today in Chinese Traditional Medicine 
(Cragg et al., 2008; Dias et al., 2012). 
According to the World Health Organization (WHO), by 2012 about 80% of people still 
depended on traditional medicines as primary health care, and 80% of the 122 plant-based 
drugs were being used according to their ethnopharmacological use (Cragg and Newman, 
2013; Dias et al., 2012). Medicines considered basic and essential by WHO are about 250, 
11% of which are exclusively of vegetable origin. The vast majority of synthetic drugs originate 
from natural precursors, and over 60% of antitumor and anti-infective drugs are based on 
plants natural metabolites (Bandaranayake, 2006; Robbers et al., 1996; Rout et al., 2009). 
Two well-known examples of drug discovery from natural products are acetylsalicylic 
acid (aspirin), obtained from salicin, a natural product isolated from Salix alba L. (Dias et al., 
2012; Mishra and Tiwari, 2011), and morphine isolated from Papaver somniferum L. (Cragg 
and Newman, 2013; Cragg et al., 2008; Dias et al., 2012). Thus, plants can have an important 
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role on pharmacological research and drug development, not only when the bioactive 
compounds are directly used as therapeutic agents, but also when they are used as raw 
material for drug synthesis, or as a base model for new biologically active compounds 
(Mendonça-Filho, 2006; Swain, 1972).   
However, validating and using plants as a phytopharmaceutical requires careful and 
exhaustive applied research, to set this resource at the same level of conventional 
pharmaceutical products (Batanouny et al., 1999). In order to keep up with the drug discovery 
market, the research on natural products needs to improve screening, isolation, and chemical 
characterization (Butler, 2004; Dias et al., 2012).  
Since less than 10% of the world’s biodiversity has been evaluated, many potential 
natural lead compounds await discovery of their biological activity (Dias et al., 2012). Thus, it 
is imperative to improve medicinal plants study, and learn from the traditional health 
practitioners that bear the knowledge of many generations of trial and error.  
I.2 Plectranthus plants L’ Héritier genus (Lamiaceae) 
Plants from the Plectranthus L’ Hérit. genus belong to the Lamiaceae family, and are 
also known as spur flowers (Rice et al., 2011). The Lamiaceae is well known for its biologically 
active essential oils, common to many family members, its ornamental and culinary herbs such 
as basil, lavender, mint, rosemary, sage, and thyme (Naghibi et al., 2005; Wagstaff et al., 
1998).  
Being easy to grow, there are about 350 species of Plectranthus widely distributed 
across the warm and tropical areas of Africa, Asia and Oceania. These plants were probably 
brought to the Mediterranean areas due to the 16th century Portuguese maritime discoveries 
(Rijo et al., 2014a; Rosa et al., 2015).  
The genus Plectranthus was first described in 1788 by Charles L’ Héritier a keen 
French botanist who named these plants after the Latin “plecton” meaning spur, and “Anthos” 
for flower (Rijo et al., 2013b). This particular genus is widely known for their biologically active 
essential oils regarding its aromatic nature (Rice et al., 2011), and so it is commonly used in 
traditional medicine (see Table 1). In fact stems, leaves, roots, and tubers are used to treat 
around thirteen categories of ailments as described in Economic Botany Data Collection 
Standard (Cook, 1995).  
Some traditional application include uses as vermicides, antiseptics, purgatives, pain 
relief, and nausea (Rijo et al., 2005), making the Plectranthus plants the most recurrent 
medicinal plants cited in literature (Gaspar-Marques et al., 2006; Lukhoba et al., 2006).   
Generally, Plectranthus species are rich in essential oils having more than 0.5% of volatile oil 
on a dry weight basis, composed mainly of mono- and sesquiterpenes (Abdel-Mogib et al., 
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2002). Also these plants are notorious as household (culinary, fly repellent, aromatic) ornament 
and for horticulture (gardens, bonsai, rockeries), since they are very aromatic, produce 
stunning flowers, and are plague resistant (Lukhoba et al., 2006; Rice et al., 2011). 
 
Table 1 Traditional medicinal uses of the studied Plectranthus spp. plants  
Plectranthus spp. Ethnobotanical uses Reference 
P. madagascariensis  
(Pers.) Benth. 
 
Cough; colds; asthma; scabies; small 
wounds; skin ailments; 
infection 
(Lukhoba et al., 2006) 
P. grandidentatus Gürke 
 
Blood circulation; infection (Lukhoba et al., 2006) 
P. neochilus Schltr. 
 
Hepatic insufficiency; dyspepsia; anti-
helmintic; infection 
(Gabriel et al., 2016; 
Lukhoba et al., 2006) 
P. ecklonii Benth. 
 
Nausea; meningitis; tuberculosis; 
antifungal; headache; allergic rhinitis; 
skin ailments; gastrointestinal infections; 
malaria 
(Rice et al., 2011) 
P. porcatus van Jaarsv. 
& P.J.D.Winter 
 
Infections (Lukhoba et al., 2006) 
P. prostratus Gürke 
 
Genito-urinary system problems (Lukhoba et al., 2006) 
P. ornatus Codd. 
 
Digestive tract (stomach and liver 
complications); diuretic; pain; fever; 
inflammations; infections 
(Lukhoba et al., 2006) 
P. saccatus Benth. 
 
Infections; fungicide; 
insect anti-feedant 
(Rijo, 2011; Wellsow 
et al., 2006) 
 
In Africa and Asia, Plectranthus are mostly used for digestive, pain, skin, and 
infections complaints whereas Caribbean populations exploited them for epilepsy symptoms 
relief (Lukhoba et al., 2006).  
Plectranthus plants are very difficult to catalogue because of the ambiguous 
morphology criteria, resulting in copious taxonomic setback. Due to these issues, one 
Plectranthus plant can be recorded with many names thus preventing suitable research on 
ethnobotanical uses (Lukhoba et al., 2006). Helpful information about the medicinal uses of 
most Plectranthus plants can be found in online databases such as NAPRALERT, CAB-direct, 
SEPASAL and Kew Library Catalogue. 
The worldwide interest in the use of medicinal plants has been growing, with its 
beneficial effects being rediscovered for the development of new drugs. Therefore, new 
therapeutic agents with specific targets and less adverse side effects, supports the need to 
extend the studies on Plectranthus plants. 
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I.2.1 Isolated compounds from Plectranthus plants 
Several phytochemical studies on Plectranthus plants have described a great number 
of isolated compounds, and Figure 1 depicts the link between Plectranthus species and 
isolated compounds, with chemical structures and compounds number reported in this thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Studied Plectranthus plants species and related isolated compounds with internal identification 
numbers. Compounds (15) were studied in a 1:1 mixture and (16) in a 1:4 mixture. Plants pictures were 
obtained from (Van Jaarsveld E., 2006). 
 
 
 
 
(1) 
(3) 
(4) 
(2) 
(15) 
(16) 
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R1=Ac; R2= COOH 
(11R*,13E)-11-acetoxyhalima-5,13-
dien-15-oic acid  
R1= OH; R2= CH
2
OCOCH
2
CH
2
CH
3
  
(11R*,13E)-15-butyryloxyhalima-
5,13-dien-11-ol  
R1=OH; R2= CH
2
OH 
(11R*,13E)-halima-5,13-diene-
11,15-diol  
1α,6β-diacetoxy-8α,13R*-epoxy-14-
labden-11-one   
R1=Ac; R2=COOMe 
(11R*,13E)-11-acetoxyhalima-5,13-
dien-15-oic methyl ester  
R1=R2=Ac; R3=OH 
1,6-di-O-acetylforskolin 
R1=R2=Ac; R3=H 
1,6-di-O-acetyl-9-deoxyforskolin  
α-amyrin  
β-amyrin  
P. saccatus 
Chlorogenic acid 
(PS)  
Rosmarinic acid 
(Plectranthus spp.)  
Chlorogenic acid 
Figure 1 (Cont.) Studied Plectranthus plants species and related isolated compounds with internal 
identification numbers. Compounds (14) were studied in a 1:1 mixture and (14) in a 3:1 mixture. Plants 
pictures were obtained from (Van Jaarsveld E., 2006). 
(6) (5) 
(9) 
(10) 
(8) 
(7) 
(14) 
(14) 
(11) 
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The main compounds found in Plectranthus plants are abietane, phyllocladane, 
kaurane, clerodane and labdane diterpenoids (Figure 1), together with long-chain alkylphenols, 
aristolane sesquiterpenes, ursane, oleane, and lupine triterpenois, flavonoid, and phenolic 
compounds (Naghibi et al., 2005; Rijo et al., 2005).  
Terpenes are usually present in essential oils and resins, which include over 10,000 
compounds and are divided into mono-, di-, tri- and sesquiterpenes, depending on the number 
of carbon atoms and isoprene (C5H8) groups (Doughari, 2012; Lovkova et al., 2001). 
Lamiaceae is one of the families where diterpenes have been found, and they can be divided 
in 91 skeletons, although the majority belong to the abietane skeleton (Rijo, 2011). 
Isolation of diterpenes usually requires organic extracts together with maceration, 
ultrasound, or super critical fluid extraction methods (Rijo et al., 2012). For higher isolation 
efficacy, there should be an adequate selection of solvents with different polarities, according 
to the desired compounds (usually with greater scientific relevance like phenols, terpenes and 
flavonoids).  
The most common organic solvents have intermediate polarity such as acetone, 
dichloromethane and ethyl acetate, or high polarity like methanol (Rijo et al., 2005, 2014a, 
2014b; Waksmundzka-Hajnos and Sherma, 2011).  
The often used maceration technique is long-lasting, environmentally unfriendly, 
hazardous and with some associated human toxicity. However, other extraction methodologies 
can overcome these problems and simultaneously extract the decomposable highly 
oxygenated terpenes contained in some Plectranthus plants (Marques et al., 2002).  
For natural products extraction and isolation, supercritical fluid extraction (SCF), 
especially employing supercritical CO2, has become a widespread choice. Cutting-edge 
technologies allow precise regulation of changes in temperature and pressure, and thus 
manipulation of the solvating property of the SCF. These settings enhance the quality of 
extraction of a wide range of natural products (Bernardo-Gil et al., 2011). 
Structural identification of the metabolites is based on physicochemical and 
spectroscopic data, typically UV, IR, 1H and, 13C NMR spectra. Usually NMR can be further 
completed with 2D COSY, TOCSY, gHSQC, gHMBC, and 1D NOESY spectra, mass spectra, 
and elemental analysis (Maria Fátima Simões, 2010; Rijo et al., 2005). 
I.2.1.1 Diterpenes  
Diterpenes have a wide structural variability due to their singular roles in plant growth 
development, and in the resistance to environmental stress (Rijo et al., 2013b). These 
compounds have a hydrocarbon skeleton, mostly cyclic, and highly oxygenated with hydroxyl, 
carbonyl, and carboxylic groups in an aliphatic or aromatic framework (Rijo et al., 2014b; Maria 
Fátima Simões, 2010; Coutinho et al., 2009; Abdel-Mogib et al., 2002). It is the cyclization 
 
 
8 
 
method of the carbonated skeleton allied with the oxygenated groups that gives diterpenes the 
wide range of pharmacological abilities (Rijo et al., 2013b). Some of the most common 
diterpene skeletons can be found in Figure 2. 
Due to their high boiling point, diterpenes are not considered as essential oils, but rather 
as a resin, the remaining material after steam distillation (Wang et al., 2005). 
 
 
I.2.1.1.1 Abietane diterpenes 
Abietane diterpenes (mainly isolated from P. madagascariensis, P. grandidentatus and 
P. ecklonii, are the skeleton with the highest occurrence and most widespread in Lamiaceae.  
Indeed the royleanone structure of abietane diterpenes, as well as its derivatives, are 
already extensively known for their antimicrobial, cytotoxic, antiproliferative, and antifungal 
activities (Rijo et al., 2013a, 2013b; Pereira et al., 2015; Rijo et al., 2014b; Burmistrova et al., 
2015, 2013; Rijo et al., 2012).  
Two of most the promising metabolites are Parvifloron D and 7α-acetoxy-6β-
hydroxyroyleanone. Because of the oxidized abietane and phenol groups, these compounds 
show a wide range of biological activities (Figure 3). Biological activity has been improved by 
their derivatization into more bioactive compounds such as 6β,7α-dihydroxyroyleanone or 
ester derivatives (Rijo, 2011). 
Parvifloron D, isolated from P. ecklonii is widely known for its toxicity, but has also been 
reported with high antioxidant power at in vitro assays, suggesting an interesting efficacy in 
converting free radicals into more stable products. However, these do not take into account 
the compound bioavailability or toxicity at in vivo systems (Rosa et al., 2015). 
Figure 2 Pathway of the halimane, labdane, pimarane, beyerane, clerodane, abietane and kaurane 
diterpenoid skeletons, widely isolated from Plectranthus species, showing the numeration of the 
hydrocarbon skeleton. Adapted from (Rijo et al., 2013b). 
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 The quinone moiety present in abietane diterpenes compounds has been associated 
with antimycobacterial, antimicrobial, and antitumoral activities (Gaspar-Marques et al., 2006; 
Rijo, 2011; Rijo et al., 2010, 2014b). Often found in nature, quinones represent important 
features at stabilizing free radicals in many biological systems suffering from oxidative stress, 
protein inactivation through irreversible reactions enhancing antimicrobial activity, and 
intermediate melanin synthesis pathway in human skin (Rijo, 2011; Riley, 1997; Shadyro et 
al., 2002). 
 
Figure 3 Structural representation of three abietane diterpenes, Parvifloron D (A), 7α-acetoxy-6β-
hydroxyroyleanone (B), and 6β,7α-dihydroxyroyleanone (C). Here are also depicted some of the most important 
structural characteristics granting a wide biological activity. Adapted from (Rijo, 2011). 
Structure activity relationships (SAR) analyses have shown that due to their amphipathic 
character, these diterpenes can damage bacteria cytoplasmatic membrane. Also, they can 
increase lipophilicity and/or promote hydrogen-bonding of the hydrophilic moiety (Rijo et al., 
2014b). The cytotoxic and antiproliferative abilities against human tumor cells are probably due 
to their alkylating properties (Burmistrova et al., 2013, 2015).  
Since royleanones can be present in many traditional remedies, more in vitro and in vivo 
studies should be performed, to understand their medicinal value consistent with the 
ethnopharmacological uses. 
I.2.1.1.2 Labdane diterpenes 
By 2005 the isolation of new diterpenes concerning the labdane skeleton was reported 
(Rijo et al., 2005). These diterpenes had a forskolin-like backbone (isolated from P. ornatus at 
ethyl acetate extract, see Figure 1), one of the most interesting compounds originally obtained 
from Plectranthus barbatus Andr. (also known as Coleus forskohlii Briq.) (Rijo et al., 2005, 
2013b).  
Forskolin compounds are specially notorious for several biological activities, regarding their 
cardiotonic, platelet aggregation inhibition, and anti-inflammatory properties (Klatz and 
Goldman, 2003; Rijo et al., 2005). Also, forskolin (Figure 4) has a catecholamine-like action by 
increasing intracellular cyclic adenosine monophosphate (cAMP), through the activation of 
adenylate cyclase. Previous studies suggest that this activation occurs in synergy with a wide 
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range of hormones and neurotransmitters (Bone and Mills, 2013). This interesting bioactivity 
leads to vasodilatory properties, and improved fat loss in double-blind clinical trials (Bone and 
Mills, 2013; Hayashida et al., 2001; Pizzorno and Murray, 2013). 
Regarding the presence of non-volatile compounds, 1,6-di-O-acetylforskolin (Figure 4B) is 
obtained by acetylation of forskolin, whereas 1,6-di-O-acetyl-9-deoxyforskolin (Figure 4C) is 
an intermediate of forskolin, starting with 9-deoxyforskolin. Although the potential therapeutic 
benefit of forskolin-like compounds, there is a concern about the use of these products on drug 
metabolizing enzymes in the liver (Lukhoba et al., 2006). 
Another labdane diterpene is Plectrornatin C depicted in Figure 4D, that was isolated from 
the acetone extract of P. ornatus. This compound was previously demonstrated to have 
moderate antifungal activity (Rijo et al., 2002), and cyclooxygenase-2 (COX-2) inhibition by 
59% at a concentration of 0.6 mM (Rijo, 2011). 
 
Figure 4 Resemblance of the chemical structures of some labdane diterpenes with relevance for Forskolin (A), 1,6-
di-O-acetylforskolin (B), 1,6-di-O-acetyl-9-deoxyforskolin (C), and Plectrornatine C (D). Here are also depicted the 
flavanone ring (in red) granting the labdanes a wide biological activity. Adapted from (Rijo, 2011). 
 As seen in Figure 4, some labdane diterpenes (A-D) seem also to be related with 
flavanones. Flavanones have been a promising source for lead compounds as the focus of 
many researches for biologically active components. Indeed, they were reported to have 
significant cytotoxic activity against leukemia and lung carcinoma cells, senescence, and 
cardiovascular diseases (Ketabforoosh et al., 2014; Shi et al., 2010). However, they are rarely 
present in natural sources, which limits the flavanone biological applications, and realizing their 
existence in Plectranthus spp. plants could bring a new light into labdane pharmacological 
activities.  
I.2.1.1.3 Halimane diterpenes 
 
Diterpenes with a halimane skeleton are mainly isolated from the acetone extract of P. 
ornatus (see Figure 1Figure ), and still have some unknown pharmacological properties. 
Considering halimane biosynthesis, they appear to be related to the labdanes by a series of 
methyl and hydride shifts (Silva et al., 2011).  
Unfortunately, studies on halimane biological activities are scarce. In 2011 some halimane 
derivatives derived from the halimane diterpene A (Figure 5), namely halimane diterpenes B-
D, were reported to be strong inhibitors of COX-2 in a range of 59 to 79% (Rijo, 2011). 
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More recently, new findings regarding tuberculosis, namely the pathogenic strain of 
Mycobacterium tuberculosis, reported the existence of tuberculosinols (Nakano et al., 2011), 
very similar in structure to halimane diterpenes. Tuberculosinols have been reported to 
suppress phagosome maturation, and inhibit phagocytosis by macrophage cells (Hoshino et 
al., 2011). More details will be discussed in Section I.3.4.  
 
Figure 5 Chemical structures of some halimane diterpenes. (11R*,13E)-11-acetoxyhalima-5,13-dien-15-oic acid 
(A), (11R*,13E)-15-butyryloxyhalima-5,13-dien-11-ol (B), (11R*,13E)-halima-5,13-diene-11,15-diol (C), and 
(11R*,13E)-11-acetoxyhalima-5,13-dien-15-oic acid methyl ester (D). Compounds B-D are derivatives from A. 
Adapted from (Rijo, 2011). 
I.2.1.2 Triterpenes and phytosterols  
Triterpenes and sterols are two types of compounds that genetically derive from the same 
squalene precursor, whose cyclic structures comprise trans or cis cyclohexane and 
cyclopropane units (Wink, 2010). Distinguishing triterpenes from sterols can be hard since they 
share common structural characteristics, therefore one possible way is by identifying their 
synthetic routes (Wink, 2010). Whereas sterols can be present in the Animalia, triterpenes are 
unique of the Plantae kingdom (Gabay et al., 2010).  
Pentacyclic triterpenes such as ursolic and oleanolic acids (Figure 6A and 6B), α- and β-
amyrin (Figure 6C and 6D), can be isolated from P. neochilus, P. ornatus, and P. ecklonii, 
using acetone or hexane extracts (Gabriel et al., 2016; Rijo et al., 2005; Simões et al., 2010). 
Oleanolic and ursolic acids are usually isolated simultaneously and are isomers that only differ 
on the methyl group at C-29 as depicted in Figure 6.  
 
Figure 6 Chemical structure of ursolic (A) and oleanolic (B) acids and their characteristic difference at C-29, α-
amyrin (C) and β-amyrin (D). Adapted from (Rijo, 2011). 
The triterpenoids α- and β-amyrins  are known for their antinociceptive properties, that 
have been demonstrated in several in vivo models (Gabriel et al., 2016; Rijo et al., 2005). 
Although the mechanisms of action are not yet fully understood, it is considered that they are 
independent from important endogenous systems (like opioidergic, serotoninergic and 
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noradrenergic), stabilizing the action of mast cell membranes involved in inflammation process 
(Backhouse et al., 2008).  
Oleanolic and ursolic acids have proven efficacy as antioxidant regarding radical 
scavenging and superoxide decrease (Ghimeray et al., 2015; Hwang et al., 2014), 
antimicrobial activities (Maria Fátima Simões, 2010), anti-inflammatory, antitumor including 
inhibition of skin tumorigenesis (Cha et al., 1998), and as potent elastase and collagenase 
inhibitors (Lee et al., 2001; Thring et al., 2009; Tu and Tawata, 2015; Ying et al., 1991).  
Phytosterols are notorious for their anti-inflammatory  properties (Backhouse et al., 2008). 
These compounds are synthesized by the mevalonate pathway of terpenoid formation, and 
can be regarded as direct precursors of steroid saponins, alkaloids, pregnanes, androstanes, 
that share the same backbone (Wink, 2010).  
Two examples of these compounds that can be isolated from Plectranthus plants, usually 
from P. ecklonii (Figure 1), are β-sitosterol and stigmasterol. These have been validated for 
anti-inflammatory and analgesic purposes (Backhouse et al., 2008; Ghimeray et al., 2015), 
although it was previously though that stigmasterol could not be considered as major anti-
inflammatory agent (García et al., 1999). Nonetheless, both compounds distinctly reduce 
myeloperoxydase activity influenced by the neutrophil migration inhibition into inflamed tissue 
(De la Puerta et al., 2000; García et al., 1999; Villaseñor et al., 2002, 2004) 
Furthermore, β-sitosterol was proven to inhibit human prostate cancer cells growth, 
revealing an effectiveness in apoptosis induction regarding prostaglandin production (Awad et 
al., 2005). According to the investigation held by Nashed et al. (Nashed et al., 2005), 
phytosterols are strongly associated with reduced plasma cholesterol concentrations and 
atherosclerosis lesions by 20% and 60% respectively, together with lowering of pro-
inflammatory cytokines (Ghimeray et al., 2015). 
I.2.1.3 Polyphenolic compounds  
Besides diterpenes, Plectranthus plants are rich in phenolic compounds (mainly 
isolated from aqueous extracts, see  Figure 1). Polyphenols are chemical compounds primarily 
responsible for the fruit coloring (Doughari, 2012). These are classified as phenolic acids, 
flavonoids and non-flavonoid (Doughari, 2012). In addition to their antioxidant properties, they 
play a very important role in the plant defenses against herbivores, pathogens and predators; 
therefore they have an application in the control of human agents infections (Doughari, 2012). 
Polyphenols, such as rosmarinic acid ubiquous to all Plectranthus spp., and 
chlorogenic acid obtained mainly from P. saccatus (Rijo et al., 2014a), are present in aqueous 
fractions using decoction, infusion microwave or ultrasound extraction methods (Rijo et al., 
2012, 2014a). Overall polyphenols are present in the diet and are known for their antioxidant, 
 
 
13 
 
antimicrobial, and anti-inflammatory properties (Ghimeray et al., 2015; Pereira et al., 2015; 
Sergent et al., 2010). 
I.3 Biological activities of Plectranthus natural products 
In line with the literature, the most common compounds in Plectranthus are pimarane, 
labdane, neoclerodane, halimane, and abietane diterpenes, and they have been extensively 
studied for their biological activity (Rijo et al., 2013b). 
Previous studies on the secondary metabolites samples used in this project, were 
reported in partial studies regarding their medicinal use, although the pharmacological 
properties of some compounds remain unknown (Rijo et al., 2013c).  
Although many compounds seem to have great potential according to their biological 
activities as described in Table 2, research focused on the screening and scientific validation 
of Plectranthus plants are still half-way. 
The next sections will review in more detail the state of the art concerning the studied 
biological activities of Plectranthus secondary metabolites within this thesis.  
 
Table 2 Terpene, phytosterols, and polyphenols isolated from the described Plectranthus spp. plants, and their 
main biological activities. 
Plant material Isolated compounds Biological activities References 
P. 
madagascariensis 
(PM) 
6,7-dehydroroyleanone  
Antibacterial (Gram-
positive, MRSA and 
VRE) 
(Ascensão et al., 
1998; Rijo et al., 
2014b) 
6β,7α-
dihydroxyroyleanone 
Antibacterial (Gram-
positive, MRSA and 
VRE) 
 
(Kubínová et al., 
2014; Rijo et al., 
2014b) 
P. ecklonii (PE) 
Parvifloron D 
Cytotoxic 
Antioxidant  
(Burmistrova et 
al., 2013; Rosa et 
al., 2015; Simões 
et al., 2010) 
3β-stigmast-5-en-3-ol 
Stigmasta-5,22E-dien-
3β-ol 
Oleanolic acid 
Ursolic acid 
Antimicrobial; 
Apoptotic; 
Antinociceptive; 
Antioxidant 
(Ghimeray et al., 
2015; Simões et 
al., 2010) 
P. grandidentatus 
(PG) 
7α-acetoxy-6β-
hydroxyroyleanone 
Antibacterial (Gram-
positive, MRSA and 
VRE); 
Mild cytotoxicity 
 
(Rijo et al., 2014b) 
 
P. porcatus (PP) 
(13S,15S)-
6β,7α,12α,19-
tetrahydroxy-13β,16-
cyclo-8-abietene-11,14-
dione 
Antimicrobial 
(Maria Fátima 
Simões, 2010) 
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Table 2 (Cont.) Terpene, phytosterols, and polyphenols isolated from the described Plectranthus spp. plants, and 
their main biological activities. 
Plant material Isolated compounds Biological activities References 
P. ornatus (PO) 
(11R*,13E)-11-
acetoxyhalima-5,13-
dien-15-oic acid 
Antimicrobial (MRSA); 
Antimycobacterial 
(Layre et al., 
2014; Mann and 
Peters, 2012; 
Nakano et al., 
2011; Rijo et al., 
2011) 
(11R*,13E)-15-
butyryloxyhalima-5,13-
dien-11-ol 
(11R*,13E)-halima-
5,13-diene-11,15-diol 
(11R*,13E)-11-
acetoxyhalima-5,13-
dien-15-oic methyl ester 
 
1α,6β-diacetoxy-
8α,13R*-epoxy-14-
labden-11-one 
Antibacterial (Rijo et al., 2013a) 
 1,6-di-O-acetylforskolin 
Anti-inflammatory (Rijo et al., 2005) 
 
1,6-di-O-acetyl-9-
deoxyforskolin 
P. neochilus (PN) 
 
P. ornatus (PO) 
α-amyrin 
 
β-amyrin 
Cytotoxic; 
Anti-inflammatory; 
Analgesic 
(Backhouse et al., 
2008; Gabriel et 
al., 2016; Rijo et 
al., 2005) 
P. saccatus (PS) Chlorogenic acid 
Antioxidant; 
Antimicrobial 
Anti-
acetylcholinesterase; 
tyrosinase; 
collagenase; elastase; 
Anti-inflammatory 
(Falé et al., 2012, 
2011; Ghimeray et 
al., 2015; Pereira 
et al., 2015) 
Plectranthus spp. Rosmarinic acid 
Antioxidant; 
Antimicrobial; 
Anti-
acetylcholinesterase; 
Anti-inflammatory 
(Falé et al., 2012, 
2011; Ghimeray et 
al., 2015; Pereira 
et al., 2015) 
I.3.1 Antioxidant Activity 
Reactive oxygen species (ROS) are mainly produced at mitochondrial oxidative 
phosphorylation, in cellular response to xenobiotics, cytokines, and bacterial attack. Therefore, 
oxidative stress refers to the imbalance of ROS over the cell ability to have an effective 
antioxidant response (Ray et al., 2012).  
Although a natural physiological process in biologic systems, the consequences of 
oxidative stress are present in many pathologies such as cancer, inflammation, and 
neurodegenerative disorders, renewing the interest to discover new antioxidant molecules 
(Rosa et al., 2015). When ROS are extensively generated, such as superoxide anion (O2●-), 
hydrogen peroxide (H2O2) and hydroxyl radical (HO●), redox-active metal ions like Fe2+ or Cu2+ 
originate harmful products from reacting rapidly with lipids, DNA and proteins and thus 
resulting in mutagenesis and enzymatic denaturation (Dhawan, 2014; Ray et al., 2012; Thring 
et al., 2009). Antioxidants are known to interfere with oxidative reactions either by reacting with 
 
 
15 
 
free radicals and chelating catalytic metals, or by acting as oxygen scavengers (Nsimba et al., 
2008). However, the most used antioxidants such as butylated hydroxyanisole (BHA) or propyl 
gallate, are suspected to induce liver damage and carcinogenesis in animals (Nsimba et al., 
2008). Therefore, it is widely important to discover new and eventually more powerful and less 
cytotoxic antioxidant agents from natural sources, such as Plectranthus plants.  
Polyphenols are powerful ROS scavengers, therefore they work as the most powerful 
antioxidants (Wahab et al., 2014) and they can be found in many plants, including Plectranthus 
(Rijo et al., 2012; Rosa et al., 2015). These plant-derived compounds exhibit a wide range of 
biological effects as antioxidants, such as anti-ageing, vitamin C protection and reduction of α-
tocopheryl radical (Wahab et al., 2014; Rijo et al., 2014b).  
The phenol groups present in rosmarinic and chlorogenic acids, can form relatively stable 
phenoxyl radicals, thereby disrupting chain oxidation reactions in cellular components (Pandey 
and Rizvi, 2009).  
Also, abietane diterpenes, Parvifloron D and 7α-acetoxy-6β-hydroxyroyleanone have 
been proved to have the capacity to chelate the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical. 
Parvifloron D (IC50 0.11 ± 0.018 mM) was found to be a much stronger antioxidant than 7α-
acetoxy-6β-hydroxyroyleanone (IC50 1.85 ± 0.071 mM), when compared to the positive control 
quercetin (IC50 0.0075 ± 0.0010 mM) (Rijo, 2011; Rosa et al., 2015). Besides, Parvifloron D 
can protect DNA from oxidative stress by plasmid DNA cleavage assay in the presence of 
H2O2 and Fe (II) (Rosa et al., 2015).  
Since one of the antioxidant mechanisms is the capacity to scavenge the free radicals 
that are formed during carcinogenesis, neurodegeneration, diabetes, inflammation, and ageing 
processes, an antioxidant agent can be useful as an adjuvant therapy (Falé et al., 2011; Ray 
et al., 2012).  
Also, compounds associated with reduced levels of oxidative stress, are supposed to 
have skin-protective properties, through the inhibition of natural skin-related enzymes such as 
tyrosinase, elastase, and collagenase (Chen et al., 2015; Ghimeray et al., 2015). Further 
elucidation will be given throughout section I.3.2. 
I.3.2 Inhibition of skin-related enzymes   
The skin is one of the most important organs of the body, since it provides protection 
from the external environment, and from any damage caused by the UV-light, chemicals, and 
microorganisms (Moon et al., 2010; Thring et al., 2011).  
There are many forms of skin ageing, but one the most common stress-inducing factor 
is exposure to UV irradiation, that disturbs the intrinsic pathways involving elasticity and 
pigmentation changes (Wahab et al., 2014; Thring et al., 2011; Moon et al., 2010). Solar 
 
 
16 
 
exposure causes ultimately the formation of lipid peroxides, and ROS that can overcome the 
endogenous cellular antioxidant system, thus induce proteinases capable of changing the 
matrix (Thring et al., 2009). Moreover, skin disorders are associated with increased oxidative 
stress, that enhances enzymatic activity such as tyrosinase, elastase, and collagenase 
(Ghimeray et al., 2015; Vallisuta et al., 2014). Therefore, there is an interest to identify natural 
antioxidants that can be inhibitors of these enzymes to fight against skin ageing and 
hyperpigmentation (Popoola et al., 2015; Tu and Tawata, 2015).  
I.3.2.1 Enzymes in skin pigmentation and ageing – Tyrosinase, elastase, and 
collagenase 
Tyrosinase (EC 1.14.18.1) is a bi-nuclear copper monooxygenase that catalyzes the 
first two stages of melanin biosynthesis. The copper ions are coordinated with the histidine 
residues on the active site, and are critical for catalytic activity (Chen et al., 2015; Popoola et 
al., 2015). In the initial step, L-tyrosine is hydroxylated to L-3,4-dihydroxyphenylalanine (also 
known as L-DOPA), that is further oxidized to the corresponding dopaquinone. The oxidative 
polymerization of several dopaquinone derivatives originates melanin (Masuda et al., 2009; Tu 
and Tawata, 2015), thus tyrosine is considered to be the rate-limiting regulator (Tu and Tawata, 
2015). 
 Melanin is an important cellular component responsible for skin color, and has photo-
protective properties against harmful effects of UV radiation in normal skin pigmentation. In 
contrast, abnormal pigmentation caused by formation of excessive ROS can lead to senile 
lentigines, feckles, and melasma (Chen et al., 2015; Tu and Tawata, 2015).  
Many tyrosinase inhibitors such as hydroquinone, kojic acid (IC50 0.03 mM (Masuda et 
al., 2009)), azelaic acid, electron-rich phenols, and arbutin (IC50 83.3 mM (Masuda et al., 
2009)), have been reported for their capability of inhibiting melanin overproduction (Chen et 
al., 2015). However, due to their adverse side effects, low formulation stability, and poor skin 
penetration their use is limited, hence the search for new agents from natural products. In fact, 
quercetin, a strong antioxidant compound, has been reported to highly inhibit tyrosinase 
activity (IC50 0.1 mM (Masuda et al., 2009)). 
Besides hyperpigmentation, UV irradiation can also cause changes in the extracellular 
matrix (ECM) by the breakdown of collagen, elastin, proteoglycans, and fibronectin, thus 
damaging skin collagenous tissues (Jung et al., 2014). It is believed that ROS can upregulate 
expression of several matrix metalloproteinases (MMP), and decrease the synthesis of ECM 
proteins such as collagen and elastin. In Figure 7 two signaling pathways are outlined 
according to previous studies.  
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Collagenase (EC 3.4.24.3) and elastase (EC 3.4.21.36) are two of the main enzymes 
responsible for breaking down of collagen and elastin, the major components of the connective 
tissue skin. Skin weight contains 70-80% of collagen to provide structural stability, and 2-4% 
of elastin to maintain skin elasticity (Wahab et al., 2014). These two ECM under the epidermis 
comprise fibers networks granting tensile strength of the skin the mechanical properties of the 
connective tissue (Moon et al., 2010; Thring et al., 2009; Vallisuta et al., 2014; Wahab et al., 
2014). 
Since many plants contain a wide variety of polyphenols, recent studies reported that 
these antioxidant compounds are able to protect skin against the damaging effects of ROS, 
such as photo-ageing, sagging skin, and skin-ageing (Wahab et al., 2014). Triterpenoids 
isolated from Boswellia spp., and resin and extracts from Rosmarinus officinalis have also 
been shown to have anti-elastase and anti-collagenase activity. Indeed, oleanolic and ursolic 
acids are known inhibitors of elastase (ursolic acid IC50 31 µg/mL), and collagenase (oleanolic 
acid IC50 21 µg/mL) (Baylac and Racine, 2004; Barrantes and Guinea, 2003; Thring et al., 
2009). It is believed that triterpenes bind reversibly to elastase and collagenase catalytic sites, 
since there is an activity recovery upon dilution of the enzyme-inhibitor mixture. Other 
triterpenes belonging to α- and β-amyrins have also been assessed, and the similar pentacyclic 
structure, revealed the same inhibitory effect as ursolic and oleanolic acids (Ying et al., 1991).  
 
Figure 7 Signaling pathway induced by ROS causing skin damaging. ROS up-regulated mitogen-activated 
protein kinases (MAPK) cascades that will enhance transcriptional activity of AP-1 heterodimer comprised of c-Jun 
and c-Fos, thus increasing metalloproteinases (MMP) expression. In addition, TGF-β/Smad signaling pathway is 
down-regulated by the over accumulation of ROS, decreasing the synthesis of major ECM proteins such as collagen 
and/or elastin. 
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The biochemistry of collagenase has been reported to the catalytic domain composed 
by an active zinc (Zn2+) atom linked to three aminoacid side chains, with a fourth coordination 
site occupied by a water-binding atom (Nsimba et al., 2008; Thring et al., 2009).  
Elastase is a member of the serine protease enzyme family that breaks down elastin. 
Damage to the skin results in reduced skin elasticity and the loss of linearity of dermal elastic 
fibers, thus inducing wrinkling and sagging. Therefore, certain elastase inhibitors have been 
utilized for dermatological preparations to reduce the wrinkling and aging of skin (Vallisuta et 
al., 2014).  
Many phenolic compounds, such as catechin and epigallocatechin gallate (EGCG) 
have been reported to be not only metal chelators, thus inhibiting collagenase by making Zn2+ 
unavailable (Jung et al., 2014; Thring et al., 2009), but also the hydroxyl and/or benzene group 
of polyphenols can form hydrogen bonds or hydrophobic interaction with elastase functional 
groups (Wahab et al., 2014). Most compounds contain carboxylic, hydroxamic, or sulfonamide 
groups that coordinate the zinc ion in the active site of the MMP using two main binding modes: 
hydrogen bonding and electrostatic interactions (Nsimba et al., 2008).  
The bioactive inhibitors in these enzymes can act by inducing conformational changes, 
metal-chelation, non-covalent bonding, or by reducing radicals from UV stimulation (Masuda 
et al., 2009; Wahab et al., 2014).  
Concerning Plectranthus antioxidant potential, the search for non-cytotoxic compounds 
and skin permeable for new anti-ageing, anti-sagging, and anti-hyperpigmentation skin, should 
be of great importance. Consequently, there should be an enhanced interest to study 
bioactivity that might be useful in modern formulations (Moon et al., 2010; Thring et al., 2009).
  
I.3.2.2 Acetylcholinesterase in the skin – Non-neuronal cholinergic system  
Acetylcholinesterase (EC 3.1.17) is involved in the termination of impulse transmission 
by rapid hydrolysis of the neurotransmitter acetylcholine (ACh) (Čolović et al., 2013). This 
reaction is most commonly known in numerous cholinergic pathways in the central and 
peripheral nervous systems. The enzyme inactivation, induced by various inhibitors, leads to 
acetylcholine accumulation, hyperstimulation of nicotinic and muscarinic receptors, and 
disrupted neurotransmission (Čolović et al., 2013; Filho et al., 2006). 
Acetylcholinesterase (AChE) is a serine hydrolase found in many types of conducting 
tissue: nerve and muscle, central and peripheral tissues, motor and sensory fibers, and 
cholinergic and non-cholinergic fibers (Čolović et al., 2013).  
Reversible AChE inhibitors play an important role in pharmacological manipulation of 
the enzyme activity. These inhibitors include compounds with different functional groups 
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(carbamate, quaternary or tertiary ammonium group), and have been applied in the diagnostic 
and/or treatment of various diseases such as myasthenia gravis, Alzheimer disease, post-
operative ileus, bladder distention, glaucoma, as well as antidote to anticholinergic overdose 
(Čolović et al., 2013; Valasani et al., 2013). 
During the past years it has become apparent that ACh is far from being exclusive of 
the nervous system (Kirkpatrick et al., 2001). In 2006 Schlereth demonstrated for the first time 
the in vivo release of non-neuronal acetylcholine from the human skin by dermal microdialysis 
(Schlereth et al., 2006). 
Several studies have been performed reporting that the human skin contains resident 
and transiently residing cells part of the extra- or non-neuronal cholinergic system, establishing 
the skin as active source and target of neurotransmitters and hormones (Kurzen et al., 2007; 
Schlereth et al., 2006). The non-neuronal cholinergic system is implicated in many skin 
functions, such as growth, differentiation, adhesion and motility, and barrier formation.  
Indeed, ACh is produced in keratinocytes, endothelial cells and most notably in immune 
competent cells invading the skin at sites of inflammation (Kurzen et al., 2007). Therefore, 
there has been an increased interest on the non-neuronal cholinergic system as a regulator of 
skin physiology, and pathophysiology (Kurzen et al., 2007; Schlereth et al., 2006).  
The first report on the skin non-neuronal production of ACh goes back to 1983, when 
Mark and colleagues performed parasympathetic denervation of the rat parotid gland, and still 
registered a continued production of high amounts of ACh in salivary glands  (Mark et al., 
1983). More recently, there was a study reporting skin lesions and reactions after therapy with 
acetylcholinesterase inhibitors (Golüke et al., 2014), linking with the literature information. 
Due to the underestimated endocrine action of choline on ACh receptors present in the 
different non-neuronal cholinergic systems, there are few reports on the effects of choline 
deficiency or excess on skin physiology (Kurzen et al., 2007). However, through the recent 
years many studies have been developed to better understand the role of the non-neuronal 
cholinergic system on inflammatory skin diseases (Grando et al., 2012). 
Previous studies have proven the capacity of some Plectranthus extracts, as well as of 
some of their isolated compounds, to inhibit AChE. In fact, aqueous extracts of P. ecklonii, P. 
grandidentatus, P. ornatus, P. porcatus, and P. saccatus resulted in high AChE inhibition 
probably because they are also the ones with the highest content in rosmarinic acid, 
suggesting that this compound may be responsible for the reported activity (Rijo et al., 2014a). 
Moreover, rosmarinic acid was reported with AChE inhibition activity (IC50 of 527.8 ± 
27.7 µM) (Kubínová et al., 2014). Being the main compound in the extracts of Plectranthus 
species, it would be very interesting to focus on less known Plectranthus spp. constituents, 
and search for AChE inhibition biological activity. 
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I.3.3 Anti-inflammatory activity 
Drugs in the market such as nonsteroidal anti-inflammatory drugs (NSAID) have a 
number of adverse side effects, including gastrointestinal discomfort, inhibition of platelet 
aggregation, and liver and kidney toxicity (Rijo et al., 2013a; Crofford, 2013). 
Many inflammatory diseases are associated with the synthesis of prostaglandins, which 
are also responsible for the pain and fever outcomes. The primary enzyme responsible for 
prostaglandins synthesis is the membrane-associated cyclooxygenase (COX) (Matu and van 
Staden, 2003).  
The cyclooxygenase enzyme has two isoforms, the constitutive enzyme COX-1 
responsible for the synthesis of pro-aggregate thromboxane in blood platelets, and the 
inducible enzyme COX-2 that synthetizes prostaglandins in acute inflammation, and is 
cytokine-inducible and expressed mainly in a wide range of inflammatory cells (Huss et al., 
2002; Rijo et al., 2013a).  
Modulation of the activity of the enzyme by NSAID implies that the inflammation process 
can be modified (Amessis-Ouchemoukh et al., 2014; Huss et al., 2002). Being a bi-functional 
enzyme, COX first catalyzes oxygen to arachidonic acid (AA) to produce hydroperoxide 
prostaglandin G2, and then by a peroxidase reaction, reduces the hydroperoxide to an alcohol 
(Amessis-Ouchemoukh et al., 2014).  
Celecoxib, for example, is a selective COX-2 inhibitor (IC50 values of 40 nM for COX-2 
and 15 μM for COX-1(Cao et al., 2010)), and has an improved safety profile in comparison 
with traditional NSAID that inhibit both cyclooxygenases (Huss et al., 2002; Ong et al., 2007; 
Rijo et al., 2013a).  
A variety of in vitro methodologies have been used to assess selective COX-2 inhibitors, 
is schematized in Figure 8. One method examines the effect of inhibitors on mRNA and protein 
levels, along with the effect of enzymatic activity, using cell-based assays. Another strategy 
involves identifying inhibitors that affect the isolated enzyme. The latter can be done either 
continuously, performing oxygen measurements, or non-continuously, using a stop-time assay 
to detect the produced prostaglandins through methods such as RIA, ELISA, HPLC, or 
radiotracer (Huss et al., 2002). 
Also, the N,N,N’,N’-tetramethyl-p-phenylenediamine (TMPD) oxidation assay has been 
used to evaluate potential new COX inhibitors in a microplate format. TMPD is a high oxidizable 
compound that serves as a reducing co-substrate for heme peroxidases. This works as an 
artificial electron donor that undergoes co-oxidation by PGG2 producing a blue product, 
detected at 590 nm (Petrovic and Murray, 2010).  
Although this is an indirect method, the oxidation of TMPD has been shown to accurately 
reflect the rate of conversion of arachidonic acid to PGH2 (Petrovic and Murray, 2010). 
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Figure 8 Cyclooxygenases metabolic pathway and most common strategies to evaluate COX inhibition.  
PLA2 –Phospholipases A2; PLC - Phospholipases C; PGG2 – Prostaglandin G2; PGH2 –Prostaglandin H2; TMPD - 
N,N,N’,N’-tetramethyl-p-phenylenediamine; ELISA -Enzyme-linked immunoassay. Adapted from (Petrovic and 
Murray, 2010).  
 
Under inflammatory pathogenesis nitric oxide (NO) is one of the key signaling molecules 
by over-expression of inducible NO synthase in macrophages and neutrophils (Sharma et al., 
2008; Wang and Leigh, 2006). This over-expression is caused by pro-inflammatory mediators 
such as IFN-γ, TNF-α, leukotrienes, and most prostaglandins produced by COX enzymes 
(Coleman, 2001).  
However, the best recognized inducer of inflammation is lipopolysaccharide (LPS) of 
Escherichia coli, that develops systemic inflammatory response syndrome (SIRS) in the course 
of sepsis due to Gram-negative bacteria (Guzik et al., 2003). 
NO is synthesized by three isoforms of the nitric oxide synthase (NOS): endothelial NOS 
(eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS) (Boora et al., 2014). iNOS is 
constitutively expressed only in some tissues, but is synthesized in response to inflammatory 
or pro-inflammatory mediators (Cirino et al., 2006; Coleman, 2001; Dawson and Dawson, 
1995; Guzik et al., 2003). 
Nitric oxide is produced from L-arginine aminoacid and oxygen by conversion into NO and 
L-citrulline through a five-electron oxidative process (Scheme 1) (Boora et al., 2014; Dhawan, 
2014). It is a highly reactive molecule with one unpaired electron, therefore considered a free 
radical (Dhawan, 2014; Sharma et al., 2008). The production of NO requires the presence of 
many cofactors such as FAD, FMN, NADPH, tetrahydrobiopterin, and a heme group (Cirino et 
al., 2006; Dawson and Dawson, 1995; Dhawan, 2014). 
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NOS + L-arginine + O2●- + NADPH  NO● + L-citrulline + NADPH 
NOS (Fe(II)heme) + O2●-  NOS(Fe(III)heme) + O●- 
 
 
There are several methods to measure NO in biological systems, one of these involves the 
use of the Griess reaction (Boora et al., 2014; Ridnour et al., 2000).  
The Griess method detects nitrite formed by the spontaneous oxidation of NO under 
physiological conditions (Boora et al., 2014; Sun et al., 2003). In this reaction, nitrite is first 
treated with a diazotizing reagent, like sulfanilamide in an acidic media to form the transient 
diazonium salt. This intermediate reacts with a coupling reagent, N-naphthyl-ethylenediamine 
(NED), to form a stable azo-compound. The intense purple color of the product allows high 
sensitivity colorimetric detection at 545 nm, with a detection limit of approximately 0.5 µM 
(Bryan and Grisham, 2007; Sun et al., 2003).  
There are some drugs known to inhibit NO production, but currently the most useful drugs 
are arginine analogues competing for NOS (Sharma et al., 2008), such as ω-nitro-L-arginine 
methyl ester (L-NAME) (Wang and Leigh, 2006). 
The NSAID chronic use causes intense inhibition of COX-1, and that is mainly 
responsible for the side effects previously stated. In addition, there are still some loopholes 
regarding NO molecular mechanisms of action, its target molecules and cells, and its role in 
infection and immunologically mediated diseases (Guzik et al., 2003).  
Several natural products concerning Plectranthus plants have been reported for their 
anti-inflammatory activity (Chiu et al., 2012; Lukhoba et al., 2006; Rijo et al., 2013a). 
P.barbatus and P. amboinicus are used to prevent or alleviate inflammation, according to their 
ethnobotanical reports (Lukhoba et al., 2006; Thirugnanasampandan et al., 2014). 
Forskolin compounds mainly isolated from P. barbatus, are specially notorious for their 
anti-inflammatory properties (Klatz and Goldman, 2003; Rijo et al., 2005). In addition, 
phytosterols such as β-sitosterol and stigmasterol obtained from P. ecklonii, triterpenes (α- and 
β-amyrins, oleanolic and ursolic acids), and polyphenols were validated for anti-inflammatory 
purposes (Ghimeray et al., 2015; Pereira et al., 2015; Sergent et al., 2010). The pentacyclic 
triterpene oleanolic acid, also inhibited COX-2-catalyzed PGE2 biosynthesis (IC50 87 µM) (Huss 
et al., 2002). This highlights the need to investigate the potential of Plectranthus spp. medicinal 
characteristics providing identification of new anti-inflammatory agents. 
I.3.4 Anti-mycobacterium tuberculosis activity 
According to the World Health Organization (WHO), tuberculosis (TB) is one of the 
major causes of death worldwide from an infectious disease. There are 8.7 million new cases 
Scheme 1 Production of nitric oxide 
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of active TB annually, causing an estimated 1.4 million deaths (Sandhu, 2011). The causative 
agent, Mycobacterium tuberculosis (Mtb) has evolved elaborate survival mechanisms in 
humans, allowing it to remain in a clinically latent infection state, constantly engaging the 
immune system, with the possibility of progress to the active disease (Meena and Rajni, 2010). 
Despite evidence that TB is slowly declining, the emergence and spread of Mtb 
multidrug-resistant strains represents a major challenge to the global control of the disease. 
Treatment regimens for drug-susceptible TB are onerous, requiring a minimum of six months 
of treatment with four anti-tubercular drugs. Therefore, multi drug-resistant (MDR), extensively 
drug resistant (XDR) and totally drug resistant (TDR) forms are much more difficult to treat 
(Rijo et al., 2010). In these circumstances, the identification of new drugs remains nowadays 
an essential achievement in order to potentiate tools controlling Mtb infection. 
The strain H37Rv of Mtb is a harmful pathogen and some studies revealed that to 
achieve successful infection, Mtb must rely on macrophages for its replication and, more 
importantly, the macrophage should remain viable. According to the literature, Mtb has several 
survival strategies: (a) the inhibition of phagosome-lysosome fusion; (b) the inhibition of 
phagosome acidification; (c) the recruitment and retention of tryptophan-aspartate containing 
coat protein on phagosomes to prevent their delivery to lysosomes; and (d) the expression of 
members of the host-induced repetitive glycine-rich protein family of proteins (Meena and 
Rajni, 2010). 
To better understand if Mtb is inhibiting phagolysosome biogenesis by arresting 
phagosome maturation, two autophagy markers can be studied using western blot and 
immunofluorescence experiments (Romagnoli et al., 2012). Microtubule-associated protein 1 
light chain 3 (LC3) is translocated from the cytosol to the auto-phagosome membrane, and the 
autophagy adaptor protein p62/SQSTM1 (p62) works in the initiation and progression of auto-
phagosome formation, by mediating ubiquitination (Komatsu and Ichimura, 2010; Seto et al., 
2013). 
Other strategy can rely on measuring the concentration of viable bacteria in culture by 
the quantification of colony-forming units (CFU) per unit volume of culture (Peñuelas-Urquides 
et al., 2013), by plating of serial dilutions (Sieuwerts et al., 2008). Although the most reliable 
method, this might be time consuming since a primary culture is obtained in 2-4 weeks, and 
antibiotic susceptibility is determined after an additional 2-4 weeks (Ghodbane et al., 2014; 
Pathak et al., 2012). Moreover, all Mtb research must be performed at a biologic safety level 
3 laboratory, taking all safety precautions (Ghodbane et al., 2014).  
Researching for natural products active against Mtb has increased with the development 
of easier, faster, and safer screening techniques (Araujo et al., 2014). Indeed, flavones, 
flavonoids, and related metabolites have been reported to exhibit mild activity (Rijo et al., 
2010). The main mechanism is associated with the quinone ability to accept electrons and 
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producing ROS, causing cell damage, as has been described in previous section I.2.1.2 (Rijo 
et al., 2014b; Maria Fátima Simões, 2010; Coutinho et al., 2009; Abdel-Mogib et al., 2002; Rijo 
et al., 2010, 2011).  
In 2010, Rijo and co-workers (Rijo et al., 2010) reported that royleanone abietanes were 
highly active against MDR-Mtb strains, regarding 6β,7α-dihydroxyroyleanone, horminone, 6,7-
dehydroroyleanone, (MIC 12.5 mg/mL), and 7α-acetoxy-6β-hydroxyroyleanone (MIC 3.12 
mg/mL), when compared to first-line anti-tuberculous drugs isoniazid (MIC 4 mg/mL) and 
rifampicin (MIC 16 mg/mL) against the MDR-Mtb strain (Rijo et al., 2010).  
These results first exalted that royleanone abietanes isolated from Plectranthus spp. are 
highly potent against MDR-Mtb strains, thus proving their worth in developing new derivatives 
in further investigations. However, their cytotoxicity could put this anti-Mtb activity in jeopardy. 
On the other hand, new findings reported the existence of two genes found in a small 
operon, Rv3377c and Rv3378c (Layre et al., 2014; Mann and Peters, 2012; Nakano et al., 
2011), specific to virulent Mycobacterium strains (Hoshino et al., 2011). The Rv3377c 
translates a diterpene cyclase class II that generates tuberculosinyl diphosphate (TPP), and 
Rv3378c encodes a diterpene synthase that acts on TPP to produce tricyclic diterpenes, 
responsible for Mtb phagosomal arrest, named tuberculosinol and isotuberculosinol (Layre et 
al., 2014; Mann and Peters, 2012; Nakano et al., 2011). These compounds are produced in 
an equimolar mixture, and they both individually and synergistically inhibit the opsonized 
zymosan particles phagocytosis (Hoshino et al., 2011; Mann and Peters, 2012; Nakano et al., 
2011). Although the increasing interest on tuberculosinol for TB therapy, its stereochemistry 
has not been clearly established (Buter et al., 2016).  
Interestingly, these compounds were found to be very similar to the halimane diterpenes 
isolated from Plectranthus spp. Therefore, it seems appropriate to find new enantiomeric 
derivatives from Plectranthus spp. with higher affinity than TPP to the diterpene synthase 
encoded by Rv3378c (Chan et al., 2014; Hoshino et al., 2011). The derivative would then 
interact with the binding site, thus inhibiting the production of tuberculosinols, ultimately 
avoiding the phagocytosis suppression (Layre et al., 2014; Mann and Peters, 2012). 
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I.4 Objectives 
Concerning all the biological activities described for the secondary metabolites of 
Plectranthus spp., it was decided for this thesis to perform a wide biological screening for some 
Plectranthus species regarding isolated compounds and plant extracts. The focus of the work 
compiled in this report concerned the following main goals: 
 
1) Extracts preparation from the plant material Plectranthus grandidentatus, Plectranthus 
ecklonii, Plectranthus ornatus, Plectranthus madagascariensis, Plectranthus porcatus, 
Plectranthus neochilus, and Plectranthus prostratus; 
 
2) In vitro antioxidant study of the acetone, ethyl acetate, and methanol extracts through the 
DPPH radical scavenging assay; 
 
3) Explore the anti-inflammatory activity of some Plectranthus spp. isolated compounds by 
means of nitric oxide quantification, on lipopolysaccharide-stimulated mouse monocyte 
macrophages cell line; 
 
4) Assess isolated compounds and plant extracts at in vitro inhibition of skin-related enzymes 
i) Acetylcholinesterase enzyme inhibition using the Ellman colorimetric assay; 
ii) Tyrosinase, elastase, and collagenase inhibition, using adjusted colorimetric 
assays; 
 
5) Evaluate Mycobacterium tuberculosis growth after macrophage infection and treatment 
with selected isolated compounds, using the colony-forming unit assay. 
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II. EXPERIMENTAL SECTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
II.1 Reagents and materials 
2,2-diphenyl-1-picrylhydrazyl (DPPH), acetylcholinesterase (AChE), acetylcholine iodide ≥ 
98% (AChI), L-tyrosine, kojic acid, tyrosinase from mushroom, N-succinyl-Ala-Ala-Ala-p-
nitroanilide (SANA), N-[3-furyl-acryloyl]-Leu-Gly-Pro-Ala (FALGPA), collagenase from 
Clostridium histolyticum type IA, Sodium nitrite, lipopolysaccharide (LPS) from Escherichia 
coli, sulphanilamide, N-(1-naphthyl)-ethylenediamine dihydrochloride (NED), 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT),  PBS 0.1% Triton X, and PBS 
0.05% Tween 80 were purchased from Sigma-Aldrich. Tris-hydroxymethylaminomethane 
(Tris) base buffer and 5,5’-dithio-bis-(2-nitrobenzoic acid) (Ellman reagent, DTNB) were bought 
from VWR International Prolabo. 1,2,3,4-Tetrahydro-5-aminoacridine (Tacrine) was obtained 
from Cayman Chemical Company. Elastase from porcine pancreas was acquired from Alfa 
Aesar. Tricine buffer was purchased from Amresco. Phosphoric acid, dimethyl sulphoxide 
(DMSO) and methanol was bought from Merck; RPMI, fetal bovine serum (FBS), trypsin, L-
glutamine, and penicillin/streptomycin were provided by lonza. RPMI 1640 medium was from 
BioWhittaker. Anti-CD14 conjugated magnetic microbeads was from Miltenyi. Lymphoprep 
was obtained from Cedarlane. Middlebrook 7H10 agar plates were obtained from BD 
bioscience, 262710. Mycobacterium tuberculosis H37Rv (ATCC 27294; American Type 
Culture Collection, biologic safety level 3) and murine leukemic monocyte-macrophage cell 
line (RAW 264.7, biologic safety level 2) were obtained from Faculty of Pharmacy and Centre 
for Neurosciences and Cell Biology (University of Coimbra, Portugal). CytoTox® 96 Non-
Radioactive Cytotoxicity Assay kit was from Promega.  
II.2 Equipment 
For the plants extracts preparation, a microwave oven at 2.45GHz, ultrasonic apparatus 
from VWR, rotary evaporator from IKA and a lyophilizer FreeZone 25 from Labconco were 
required. For the compounds isolation methodologies, melting-points were determined on a 
Kofler block, optical rotations were measured on a Perkin-Elmer 241 MC polarimeter, UV 
spectra were recorded on a Perkin-Elmer Lambda 2 UV/vis spectrophotometer, IR spectra 
were obtained on a Perkin-Elmer Spectrum One spectrophotometer, NMR spectra were 
recorded on a Varian INOVA-400 Spectrometer, mass spectra were obtained in a Hewlett-
Packard 5973 spectrometer and electro spray ionization on a Hewlett-Packard 1100 
spectrometer, LC/MS was performed in Agilent 6520 Accurate-Mass QTOF apparatus, and 
elemental analysis in a LECO CHNS-932 apparatus. For the antioxidant assay, the 
absorbance values were read in a UV-Vis spectrometer. The enzymatic assays required a 
microplate reader from Thermo-Fisher Scientific, and incubators from Memmert and Heidolph. 
Regarding the anti-inflammatory assays, biosafety level 2 cabinet from Telstar was used, as 
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well as a CO2 incubator from Binder, inverted microscope from Motic, and a microplate reader 
from BioTek. Concerning the assays for Mycobacterium tuberculosis assays, biosafety level 3 
cabinet from Biobase, CO2 incubator, inverted microscope and microplate reader were utilized. 
II.3 Plant material and preparation of extracts 
Plectranthus spp. medicinal plants from South Africa were cultivated in Instituto 
Superior de Agronomia campus (Lisbon). Eight Plectranthus species were studied: 
Plectranthus grandidentatus Gürke, Plectranthus ecklonii Benth., Plectranthus ornatus Codd., 
Plectranthus madagascariensis (Pers.) Benth. Plectranthus porcatus van Jaarsv. & 
P.J.D.Winter, Plectranthus neochilus Schltr., Plectranthus prostratus Gürke and Plectranthus 
saccatus Benth. Extraction methods were performed according to previously established 
literature procedures, with slight modifications (Pereira et al., 2015).  
The organic extracts were prepared using methanol, ethyl acetate, and acetone as 
solvents. The extracts were obtained using 10 ± 0.010 g of the aerial parts of air dried and 
powdered plants, in 200 mL of the corresponding organic solvents. Each was submitted to 
sonication at room temperature, for 1 hour. The organic extractions were filtered to round-
bottomed flasks and were set in the rotary evaporator for vacuum evaporation at 40-50ºC. The 
sample size contained twenty-one organic extracts. The crude extracts were stored at 20 
mg/mL in DMSO. 
The aqueous extracts of the medicinal plants were performed with 10 ± 0.010 g of the 
aerial parts of dried and powdered plants, in 150 mL of bi-distilled water (Milli-Q). The mixtures 
were subject to microwave-assisted extraction for 3 minutes, at a continuous irradiation of 2.45 
GHz. The aqueous extractions were also filtered, and prepared for lyophilisation, being 
separated into 1 mL aliquots (in triplicate) and frozen at −20ºC, resulting in 7 aqueous extracts 
in triplicate. After lyophilisation the extracts were weighed and stored at 10 mg/mL in bi-distilled 
water (Milli-Q) at −20ºC.  
II.4 Isolated compounds 
The studied Plectranthus plants compounds were previously obtained and 
characterized by the partners in the CBIOS laboratory of Food Science and Phytochemistry 
Laboratory (Universidade Lusófona de Humanidades e Tecnologias, Lisboa, Portugal).  
The samples of the isolated compounds for the screening were obtained by a 
phytochemical study that was previously performed in the described plants, using bioguided 
studies. The structural elucidation of the bioactive metabolites was based in physicochemical 
data (melting point, specific rotation), mostly spectroscopic data UV, IR, 1D- and 2D- 1H and 
13C RMN spectra, mass spectra, elementary analysis and comparison with bibliographic data.  
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The compounds will be further denoted for their internal number described in Table 3. 
 
Table 3 Terpene, phytosterols, and polyphenols isolated from the described Plectranthus spp. plants, and 
correspondent sample numbers, prepared at 10 mg/mL in DMSO. 
 
Plant material Isolated compounds Compound nr. 
P. grandidentatus (PG) 7α-acetoxy-6β-hydroxyroyleanone 1 
P. madagascariensis 
(PM) 
6β,7α-dihydroxyroyleanone 2 
6,7-dehydroroyleanone  3 
P. ecklonii (PE) 
Parvifloron D 4 
3β-stigmast-5-en-3-ol 
Stigmasta-5,22E-dien-3β-ol 
Oleanolic acid 
Ursolic acid 
15 
Mixture 1:1 
 
16 
Mixture 1:4 
P. porcatus (PP) 
(13S,15S)-6β,7α,12α,19-tetrahydroxy-
13β,16-cyclo-8-abietene-11,14-dione 
6 
P. ornatus (PO) 
(11R*,13E)-11-acetoxyhalima-5,13-dien-
15-oic acid 
5 
1α,6β-diacetoxy-8α,13R*-epoxy-14-
labden-11-one 
7 
(11R*,13E)-11-acetoxyhalima-5,13-dien-
15-oic methyl ester 
8 
(11R*,13E)-15-butyryloxyhalima-5,13-
dien-11-ol 
9 
(11R*,13E)-halima-5,13-diene-11,15-diol 10 
1,6-di-O-acetylforskolin 
13  
Mixture 1:1 
1,6-di-O-acetyl-9-deoxyforskolin 
P. neochilus (PN) 
 
P. ornatus (PO) 
α-amyrin 
 
β-amyrin 
14 
Mixture 3:1 
P. saccatus (PS) Chlorogenic acid 11 
Plectranthus spp. Rosmarinic acid 12 
 
II.5 Antioxidant activity 
Radical scavenging assay with 2,2-diphenyl-1-picrylhydrazyl (DPPH)  
The free radical scavenging activity of the organic extracts (1.0 mg/mL in DMSO) was 
evaluated using the DPPH assay according to the method used beforehand (Martins et al., 
2013; Rijo et at., 2014a). All of the extracts were dissolved in ethanol 70% (w/v), mixed with 
 
 
30 
 
DPPH solution (100 mM in ethanol) and incubated at room temperature for 30 minutes, in the 
dark. Each sample was assayed in triplicate. 
The absorbance was monitored at 517 nm against a blank containing the same 
concentration of the organic extracts in ethanol, and the scavenging activity (%) was 
determined using Equation 1. 
 
Scavenging activity (%) = Abs control − (
Abs sample-Abs blank
Abs control
)×100  
 
II.6 In vitro inhibition of skin-related enzymes 
II.6.1 Anti-acetylcholinesterase enzymatic assay 
The acetylcholinesterase (AChE) inhibition assay was performed according to previous 
methodologies (Rijo et al., 2014a). For this assay the aqueous extracts have been previously 
studied in other work groups, hence only organic extracts were tested to evaluate preliminary 
bioactivity. 
The Ellman reagent (3 mM) was prepared in 50 mM HEPES buffer (pH 8.0) 
supplemented with 20 mM MgCl2 and 50 mM NaCl. The substrate AChI was prepared in bi-
distilled water at 15 mM, and AChE was dissolved in 50 mM HEPES buffer (pH 8.0), in order 
to obtain 1 mL aliquots of 1000 U.  
The assay was performed with 98 µL of HEPES buffer, 30 µL of the samples (0.1 
mg/mL) and 7.5 µL of acetylcholinesterase (50 U). These were incubated for 15 minutes at 
25ºC before adding 22.5 µL of acetylcholine iodide and 142 µL DTNB, to start the reaction.  
Positive control was performed with 3 µM tacrine (IC50 = 184 nM, (Jin, 2014)), and 
negative controls with the respective sample solvent at the same concentration tested. 
Absorbance was measured at 405 nm, immediately after starting the reaction, and then 
every 30 seconds for 3 minutes, in a 96-well microplate reader. 
All assays were performed in triplicate, and the inhibition percentage was determined using 
the following equations 2a) and 2b). 
 
2a)  Velocity reaction of control or inhibitor = 
Corrected absorbance (nm)
time ( min )
 
 
2b) Inhibitor activity (%) = 100- (
100 × Velocity reaction of inhibitor
Velocity reaction of control
)  
For the AChE activity, the absorbance increase was registered by the equation 2a) for the 
velocity reaction of control (ΔAbs405nm/min), which should be in the linear range. The results 
are expressed has percentage inhibition (%) of each sample tested. 
Equation 1: 
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II.6.2 Anti-tyrosinase enzymatic assay 
The tested compounds and extracts were assayed for the anti-tyrosinase activity with 
modifications (Moon et al., 2010). For this assay all the organic and aqueous extracts were 
assessed, as well as isolated compounds (1-7) and (11-12).  
The substrate L-tyrosine 0.5 mM was prepared in phosphate buffered saline (PBS) 50 
mM (pH 6.8), and kojic acid 0.8 mM (IC50 = 43.7 µM, (Yamauchi et al., 2011)) was used as 
positive control. Negative controls were performed with the sample solvent at same 
concentration. 
The assay was performed in 180 µL L-tyrosine and 10 µL of the tested samples (50 
µg/mL) incubated for 5 minutes at 37ºC, before starting the reaction with 10 µL tyrosinase 
(5000 U). The reaction mixture was incubated for 5 minutes more at 37ºC and the absorbance 
read at 450 nm for 10 minutes (reading every 2 minutes) in a 96-well microplate reader. 
All assays were performed in triplicate, and the inhibition percentage was determined using 
the equations 3a) and 3b). The absorbance increase was registered by the equation 3a) for 
tyrosinase velocity reaction of negative control (ΔAbs450nm/min), which had linear increase. The 
results are expressed has percentage inhibition (%) of each sample tested. 
 
3a)   Velocity reaction of control or inhibitor = 
Corrected absorbance (nm)
time ( min )
 
 
3b)   Inhibitor activity (%) = 100- (
100 × Velocity reaction of inhibitor
Velocity reaction of control
)  
 
II.6.3 Anti-collagenase enzymatic assay 
The anti-collagenase enzymatic assay was optimized based on several methods 
reported in literature (Wahab et al., 2014; Thring et al., 2011, 2009; Van Wart and Steinbrink, 
1981). In this method the organic and aqueous extracts were tested for collagenase inhibition, 
as well as the compounds (1-7) and (11-12). 
The synthetic substrate N-[3-furyl-acryloyl]-Leu-Gly-Pro-Ala (FALGPA) 0.1 mM was 
dissolved in tricine buffer 50 mM (pH 7.5) supplemented with 400 mM NaCl and 10 mM CaCl2, 
knowing that 1 U hydrolyzes 1 µmol of FALGPA per minute, at 25ºC, in the presence of calcium 
ions.    
Collagenase was prepared in the assay buffer at 1 U, and 40 µM of epigallocatechin 
gallate (EGCG) was used as a positive control (IC50 0.9 mM (Wittenauer et al., 2015)), whereas 
negative controls were the correspondent samples solvent at same concentration. 
The assay mixture containing 80 µL of tested samples (0.1 mg/mL) and 100 µL 
collagenase was incubated for 10 minutes at 37ºC, before starting the reaction with 20 µL 
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FALGPA. The assay was performed in triplicate and absorbance read at 405 nm for 10 
minutes, continuously.  
The inhibition percentage was determined using the equations 4a) and 4b). For the 
collagenase activity, the absorbance decrease was registered by the equation 4a) for the 
velocity reaction of negative control (ΔAbs405nm/min), which was in the linear range. The results 
are expressed has percentage inhibition (%) of each sample tested. 
 
4a)   Velocity reaction of control or inhibitor = 
Corrected absorbance (nm)
time ( min )
 
 
4b)   Inhibitor activity (%) = 100- (
100 × Velocity reaction of inhibitor
Velocity reaction of control
) 
 
II.6.4 Anti-elastase enzymatic assay 
The anti-elastase enzymatic assay was based on spectrophotometric methods 
described in literature, with some modifications (Thring et al., 2011; Wahab et al., 2014; Jung 
et al., 2014; Bieth et al., 1974). For this assay all the organic and aqueous extracts were tested, 
as well as the following isolated compounds: (1-7) and (13-17). 
N-succinyl-Ala-Ala-Ala-p-nitroanilide (SANA) 1 mM was used as substrate, dissolved 
in Tris-HCl buffer 50 mM (pH 8.0), knowing that 1 U enzyme converts 1 µmol of SANA per 
minute in this buffer at 25ºC. Ursolic acid at 0.1 mg/mL was the positive control (IC50 = 31 
µg/mL, (Masuda et al., 2009)), and negative controls were the respective samples solvent at 
the same tested concentration. 
Elastase (6 U) and the samples (0.1 mg/mL) were added, and the mixture was 
incubated at 25ºC for 10 minutes. The reaction was initiated by adding 20 µL of SANA and 150 
µL of Tris-HCl buffer. 
Absorbance was measured at 405 nm immediately after starting the reaction, and then 
every 30 seconds for 3 minutes, in a 96-well microplate reader. 
All assays were performed in triplicate, and the inhibition percentage was determined using 
the equations 5a) and 5b). For elastase activity, the absorbance increase is registered by the 
equation 5a) for the velocity reaction of negative control (ΔAbs405nm/min) that was in the linear 
range. The results are expressed has percentage inhibition (%) of each sample tested. 
 
5a)   Velocity reaction of control or inhibitor = 
Corrected absorbance (nm)
time ( min )
 
 
5b)   Inhibitor activity (%) = 100- (
100 × Velocity reaction of inhibitor
Velocity reaction of control
)  
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II.7 Anti-inflammatory activity 
This research was developed at the Centre for Marine Sciences (CCMAR), at the 
MARbiotech laboratories, University of Algarve, Faro, Portugal, under the supervision of 
Doctor Luísa Custódio. 
II.7.1 Cytotoxicity assay with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) 
Cell viability was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay on RAW 264.7 macrophage cell line, as previously described elsewhere 
(Rodrigues et al., 2014, 2016). Isolated compounds tested were (1), (3-4), (6-8), and (12-15). 
The cell line was maintained in RPMI culture medium supplemented with 10% FBS, 
1% L-glutamine (2 mM), and 1% penicillin (50 U/mL) / streptomycin (50 μg/mL), at 37°C in a 
humidified atmosphere with 5% CO2. The cells were re-suspended in medium every 48 hours 
with a cell scraper, until approximately 80% confluency was reached. 
After reaching the desired confluency, 1.0×103 cells/ well were plated in a 96-well plate 
and incubated during 24 hours (overnight) in RPMI medium at 37ºC. 
All samples were tested at 8 concentrations, comprising 100, 50, 25, 12.5, 10, 5, 2.5, 
and 1 µM. For each sample 100 µL of compounds was added to the cells, and incubated at 
37ºC throughout 24 hours. Control cells were treated only with DMSO at 0.5%, and with RPMI 
medium (100% cell viability).  
Afterwards, 20 µL of MTT (5 mg/mL in PBS buffer) was added and incubated for 2 
hours. Finally, 150 µL of DMSO was added to dissolve the formazan crystals, and the 
absorbance was measured at 590 nm in a microplate reader. 
Results were expressed as cell viability (%) in comparison to the controls. Non-
cytotoxic samples were considered if cell viability was up to 80%, compared to negative 
controls RPMI medium and DMSO 0.5%.  
II.7.2 Nitric oxide quantification in LPS-stimulated RAW 264.7 cells treated with non-
cytotoxic compounds 
The anti-inflammatory properties of the isolated compounds (1), (3-4), (6-8), and (12-
15) were accessed as previously described (Rodrigues et al., 2014, 2016) at the non-cytotoxic 
concentrations. Mainly, all compounds were used, with exception for isolated compounds (1) 
and (4). RAW 264.7 cells were plated in a 96-well microplate at a density of 2.5×105 cells/ well 
with RPMI medium, and allowed to adhere, during 24 hours.  
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The ω-nitro-L-arginine methyl ester hydrochloride (L-NAME) was used as a positive 
control, at IC50 value of 29 µg/mL (Rodrigues et al., 2016). 
After this time the medium was removed, 50 µL of lipopolysaccharide (LPS) (100 
ng/mL) and 50 µL of the testing samples, were dissolved in a serum- and phenol-free RPMI 
medium, and added to each well.  
After 24 hours of incubation at 37ºC in a humidified atmosphere with 5% CO2, the NO 
production in cell culture medium was measured spectrophotometrically by the Griess method.   
Briefly, the culture supernatants (approximately 100 µL) were removed and mixed with 
100 µL of Griess reagent, which comprised 1% (w/v) sulphanilamide, plus 0.1% of NED, and 
2.5% (v/v) of phosphoric acid. The mixtures were incubated for 20 minutes at room 
temperature in the dark, and absorbance was measured at 540 nm on a microplate reader.  
The NO concentration was determined using a calibration curve obtained with several 
known concentrations (1.6, 3.1, 6.25, 12.5, 25, 50, and 100 µM) of sodium nitrite used as 
standard. Results were expressed as NO production (µM) of the LPS-stimulated RAW 264.7 
cells. 
II.8 Mycobacterium tuberculosis H37Rv growth assay 
 
Research developed under the Short-Term Scientific Mission of COST action CM1407: 
“Natural diterpenoids as potential anti-tubercular drugs”, developed at the National Institute for 
the infectious Disease Lazzaro Spallanzani, Laboratorio di Biologia Cellulare e Microscopia 
Elettronica, Rome, Italy, under the supervision of Doctor Gian Maria Fimia and Doctor 
Alessandra Romagnoli.  
II.8.1 Peripheral blood mononuclear cell (PBMC) isolation 
 
The PBMC isolation was performed as previously described (Romagnoli et al., 2012) this 
experiment, approximately 50 mL of human blood from random healthy volunteers from the 
blood bank of University “La Sapienza,” Rome, Italy (who provided written informed consent, 
approved by the ethical committee at the National Institute for Infectious Diseases), was used 
and diluted (10 mL) into five Falcon tubes containing 20 mL of sterile PBS buffer. These 
solutions were added to another set of five tubes, containing Lymphoprep to perform Ficoll 
gradient separation, in order to separate the blood components into plasma, mononuclear cells 
and red blood cells. 
The blood containing Lymphoprep was centrifuged at 2200 rpm for 20 minutes to separate 
the layers, and the mononuclear cells layers were removed.  
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For cell count, performed twice, 10 µL of PBMC was added in two Eppendorf containing 
190 µL of acetic acid that lysed the remaining red blood cells, thus only PBMC were counted.  
After counting the cells, a new centrifugation at 900 rpm was performed to remove 
platelets. Then 2.5×105 cells/ mL were mixed on separation buffer.  
The anti-CD14 magnetic microbeads were added in 50 µL/100×106 cells, for 30 minutes at 
4°C. These beads attached specifically to the monocytes CD14+ membrane receptors. 
Afterwards, the samples were centrifuged for 10 minutes and re-suspended in 3 mL of PBS 
buffer.  
An LS column was used to isolate the monocytes. The resulting sample was again 
centrifuged for 10 minutes and human serum 2% was added to the RPMI FBS 10%, L-
Glutamine medium (supplemented medium). The resulting cells were counted again with 
acetic acid, and 5.0×105 cells were plated in 48-well plate, using 3 wells for negative 
control/blank, with supplemented medium. The plated cells were incubated at 37ºC in a 
humidified 5% CO2 atmosphere, during 4 days for cell adhesion. 
II.8.2 Lactate dehydrogenase (LDH) cytotoxicity assay  
In order to evaluate cytotoxicity from compounds (1-10) exposure to macrophages, the 
lactate dehydrogenase assay was performed, using the CytoTox® 96 Non-Radioactive 
Cytotoxicity Assay kit.  
After 48 hours of cell adhesion, the cells were treated with the compounds according to 
Mycobacterium tuberculosis (Mtb) H37Rv strain minimum inhibitory concentrations, obtained 
previously, described in Table 4 (Rijo et al., 2010, 2011). 
Besides the LDH positive control from the kit, representing 100% of LDH release, 
staurosporine (STS) (IC50 250 nM (Schiller, 2004)) isolated from Streptomyces staurospores, 
a protein kinase inhibitor that induces DNA fragmentation and apoptosis, was also used as a 
positive control for the cytotoxicity assay, and was tested at 2 µM. 
 The positive controls for Mtb infection ethambutol (ETAN) and isoniazid (INH), were also 
studied, in a concentration 10-fold the MIC values (1 µg/mL, and 40 µg/mL). 
The supernatants were prepared in two dilutions (1:10 and 1:100). Next, the substrate 
mixture was prepared using the assay buffer according to fabricant instructions, and 50 µL was 
added to each well and incubated for 30 minutes in the dark. Also, a maximum LDH release 
control was performed by freezing the plates at −80ºC and heating at 50ºC. 
After incubation, 50 µL of stop solution was added and absorbance read at 490 nm in a 
microplate reader. 
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Table 4 Minimum inhibitory concentration (MIC) values (µg/mL). The MICs were used as baseline for the LDH 
cytotoxicity test macrophages derived from PBMC (Rijo et al., 2010, 2011). 
 
 
 
 
 
 
 
 
II.8.3 Macrophage infection with Mycobacterium tuberculosis, and treatment with 
compounds 
After obtaining the cytotoxicity results, macrophages were again isolated from PBMC, and 
were infected in a Biosafety Level 3 laboratory, according to previous described (Romagnoli 
et al., 2012). Macrophages were infected with Mtb at a multiplicity of infection (MOI) of 1.  
Treatment with the compounds (5) and (7-10) at the MIC values (25 µg/mL) started 2 hours 
after infection and kept until the end of the experiment, according to MIC values in Table 4. 
Ethambutol and isoniazid were used as positive controls at 10-fold the MIC isoniazid (INH) at 
1 µg/mL, and ethambutol (ETAN) at 40 µg/mL. 
After 48-hours of treatment with the selected compounds, the infected cell cultures were 
lysed in PBS 0.1% Triton X, in order to release intracellular Mtb. Serial dilutions were prepared 
in PBS 0.05% Tween 80. Aliquots (50 µL) of each Mtb dilution were plated (in triplicate), to 
determine the intracellular bacterial load with CFU counts. Viable bacteria were evaluated after 
13 days of incubation at 37°C. Values are expressed as the logarithm of CFU/mL, at the dilution 
10-3. The intracellular amount of CFU at time zero was assessed to make sure that all wells 
were infected with the same bacterial concentration and that the infecting dose was as 
expected. After the assay, Mtb was heat killed at 80°C for 1 hour, as previously described 
(Romagnoli et al., 2012). 
Compounds 
Concentration 
(µM) 
Molar mass 
(g/mol) 
MIC Mtb 
(µg/mL) 
7α-acetoxy-6β-hydroxyroyleanone (1) 64.1 390.20 
25 6β,7α-dihydroxyroyleanone (2) 71.8 348.19 
6,7-dehydroroyleanone (3) 79.5 314.42 
Parvifloron D (4) 35.9 434.52 15.6 
11R*-acetoxy-halima-5,13E-dien-15-oic acid 
(5) 
69.1 362 
25 
(13S,15S)-6β,7α,12α,19-tetrahydroxy-13β,16-
cyclo-8-abietene-11,14-dione (6) 
25 364.43 
1α,6β-diacetoxy-8α,13R*-epoxy-14- labden-
11-one (7) 
59.4 420.54 
(11R*,13E)-11-acetoxyhalima- 
5,13-dien-15-oic acid methyl ester (8) 
71.8 348 
(11R*,13E)-15-butyryloxyhalima-5,13-dien-
11-ol (9) 
66.5 376 
(11R*,13E)-halima-5,13-diene-11,15-diol (10) 81.7 306 
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II.9 Statistical analysis 
Data comparisons were conducted with one-way analysis of variance (ANOVA) followed 
by post hoc Tukey honest significant difference test, for pairwise comparisons. Analyses and 
graphical presentation were performed with the GraphPad Prism Software Version 5 
(GraphPad Software, Inc., San Diego, CA, USA). Values of p<0.05 were statistically significant. 
Results are presented as mean ± standard deviation (SD). 
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III. RESULTS AND DISCUSSION 
 
 
39 
 
III.1 Plectranthus spp. extracts 
 
In this work eight Plectranthus species were studied, P. grandidentatus Gürke, P. 
ecklonii Benth., P. ornatus Codd., P. madagascariensis (Pers.) Benth. P. porcatus van Jaarsv. 
& P.J.D.Winter, P. neochilus Schltr., P. prostratus Gürke and P. saccatus Benth.. Extracts of 
the aerial parts of the plant material dried and powdered, resulted in twenty-one bioactive 
organic extracts, and seven aqueous extracts. The organic extracts were prepared with three 
solvents, namely acetone, methanol, and ethyl acetate. Ultrasound was the selected extraction 
methodology for its efficiency (Rijo et al., 2014a). The aqueous extracts were obtained using 
the microwave extraction, since it has been proven to have additional advantages in terms of 
short duration, and high efficiency to recover the bioactive compounds (Rijo et al., 2014). 
The amount of dry weights of each plant are shown in Table  along with the resulting 
yields. The extraction resulted in approximately the same low dry residue for the microwave 
methods between 0.26% (mg/g) for P. porcatus and 0.43% (mg/g) for P. ornatus. Higher yields 
were indeed obtained for organic extracts, particularly on P. ornatus acetone extract that 
resulted in 59.9% (mg/g) of dry extract yield. Considering yield data (Table ), with exception 
for P. ornatus, methanol was the most effective solvent for this extraction methodology.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5– Extraction solvent, technique and obtained yields for each Plectranthus spp. 
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III.2 Organic extracts antioxidant activity by scavenging of DPPH 
radical 
The antioxidant capacity of the organic extracts was evaluated using the DPPH radical 
scavenging assay (Rijo et al., 2014a) (Section II.5). Several studies report the antioxidant 
activity of Plectranthus plants through radical scavenging, and DNA protection from oxidative 
stress properties (Rijo et al., 2012; Rosa et al., 2015). As shown in Figure 9, methanol extracts 
held the highest scavenging activity (20-76%), among the plants, except for ethyl acetate 
extract of P. grandidentatus (62.3 ± 0.43% p<0.0001). 
Figure 9 In vitro antioxidant activity by the DPPH radical scavenging assay of the Plectranthus spp. organic extracts. 
Twenty-two organic extracts were tested at 100 µg/mL, in triplicate, for their ability to scavenge the DPPH free 
radical. The results are presented as means percentage values, considering the absorbance of Quercetin as the 
positive control. Data are expressed as the mean ± SD (n=3) **p<0.005 ***p<0.0001 vs negative control (DPPH in 
ethanol). Values were determined by one-way ANOVA followed by Tukey HSD comparison test. 
The observed results for the methanol extracts is possibly related with the high contents of 
polyphenols in these extracts, that are known for their antioxidant activity (Quy Diem et al., 
2014). Nevertheless, there were recent discoveries on the abietane diterpenes with antioxidant 
properties, particularly concerning Parvifloron D (4) and 7α-acetoxy-6β-hydroroyleanone (1) 
(Rosa et al., 2015). The antioxidant results of P. ecklonii (methanol, 75.9 ± 1.02% p<0.0001), 
P. madagascariensis (methanol 48.4 ± 1.23% p<0.0001), and P. grandidentatus (ethyl acetate 
62.3 ± 0.43% p<0.0001), can possibly be explained by the mainly present compounds with a 
abietane backbone that have antioxidant activity (Rosa et al., 2015).  
Additionally, PE ethyl acetate (55.5 ± 1.66% p<0.0001) and acetone (56.9 ± 1.45% 
p<0.0001) extracts resulted in relatively increased radical scavenging activity, in comparison 
to the remaining plants extracts that held high values only for the methanol extract. In fact, PG 
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and PE had the most similar antioxidant activity with quercetin at 89 ± 2.5% (structural 
representation in Figure 9), a potent antioxidant compound. 
Since the organic extracts have been studied for their notorious amounts of polyphenol 
compound and abietane diterpenes compounds, identified in Plectranthus spp. plants, this 
assay validates their aptitude for the conversion of the DPPH free radical into a more stable 
molecule, thus stopping the radical chain reaction. 
III.3 Skin-related enzymatic inhibitions in vitro 
Plectranthus spp. natural products have shown antioxidant activity (Section III.2), and ROS 
can initiate complex molecular pathways for melanogenesis (Tu and Tawata, 2015), and 
activation of ECM proteases such as collagenase and elastase (Ghimeray et al., 2015).  
Several studies have been performed reporting that the human skin contains resident and 
transiently residing cells part of the extra- or non-neuronal cholinergic system, establishing the 
skin as active source and target of neurotransmitters and hormones (Kurzen et al., 2007; 
Schlereth et al., 2006). 
Therefore, to investigate if Plectranthus spp. could be useful as promising approach to 
prevent extrinsic skin aging, several in vitro assays were developed for anti- 
acetylcholinesterase, -tyrosinase, -collagenase, and -elastase activities. 
III.3.1 Organic extracts AChE inhibition in vitro 
There have been previous studies (Rijo et al., 2014a) proving the capacity of aqueous 
Plectranthus extracts, as well as of some of their isolated compounds, to inhibit AChE. In fact, 
the aqueous extracts of P. ecklonii, P. grandidentatus, P. ornatus, P. 
porcatus, P. barbatus, and P. saccatus were reported to interfere with 
AChE activity. Moreover the eminent AChE inhibition can be probably 
be related to high contents in rosmarinic acid (IC50 527.8 ± 27.7 µM), 
that has been previously tested (Rijo et al., 2014a). 
The majority of AChE inhibitors reported so far have alkaloid 
characteristics, such as tacrine represented in Figure 10, and there 
are few terpene-like inhibitors reported. The aqueous extracts have been the focus of AChE 
inhibitory assays (Rijo et al., 2014a), so in order to find potential inhibitors identities, only the 
organic extracts were tested for this assay. 
This in vitro enzymatic assay was performed by measuring the colorimetric product 
obtained from the reaction of thiocholine produced by AChE, with the Ellman reagent (DTNB), 
which was proportional to the AChE activity. The results are shown in Table 6 and represent 
Figure 10 Structural 
representation of tacrine, a 
known AChE inhibitor. 
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the inhibition percentage of AChE, calculated according to equation 2b) at section II.6.1 in 
comparison with the enzymatic activity of the negative control (ΔAbs405nm/min).  
These results demonstrate that the Plectranthus spp. organic extracts do not exert 
inhibitory properties in acetylcholinesterase in vitro (Table 6). In truth, with exception for the P. 
porcatus (PPP) and P. prostratus (PP) extracts from all solvents, and P. ornatus (PO) acetone 
extract, the inhibition of AChE was probably due to the DMSO interference with the enzyme 
(17.0 ± 0.05% of AChE inhibition). Even though, the inhibition percentage on AChE did not 
exceeded more than 23%, and are very low comparing to the positive control (tacrine) that 
could inhibit AChE by 95.65 ± 2.89%.   
Table 6 In vitro acetylcholinesterase enzymatic assay of the organic extracts obtained from seven 
Plectranthus spp. plant material. The samples represent the extracts reconstructed in DMSO at 10 mg/mL, and 
tested at 10 µg/mL from serial dilutions in HEPES buffer 50 mM (pH 8.0), until reaching 0.1% (v/v) of DMSO. Values 
represent mean ± standard deviation (SD) of the assays performed in triplicate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a The negative control: DMSO at 0.1% (v/v) with HEPES buffer 50mM (pH 8.0);  
b Positive control: Tacrine 3.0 µM. 
 
Plant material Sample AChE inhibition ± SD (%) 
P. ornatus 
Acetone 22.81 ± 2.31 
Ethyl acetate < 17 
Methanol < 17 
P. porcatus  
Acetone 19.93 ± 2.07 
Ethyl acetate 22.76 ± 0.80 
Methanol 18.47 ± 1.67 
P. prostratus 
Acetone 19.27 ± 0.12 
Ethyl acetate 18.41 ± 1.21 
Methanol 20.49 ± 1.21 
P. ecklonii 
Acetone < 17 
Ethyl acetate < 17 
Methanol < 17 
P. neochilus 
Acetone < 17 
Ethyl acetate < 17 
Methanol <17 
P. grandidentatus 
Acetone < 17 
Ethyl acetate < 17 
Methanol < 17 
P. madagascariensis 
Acetone < 17 
Ethyl acetate < 17 
Methanol < 17 
Negative control DMSO 0.1% a 17.0 ± 0.05 
Positive control Tacrine b 95.65 ± 2.89 
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As for PO acetone extract, the outcome of AChE mild inhibition was probably due to the 
presence of some labdane diterpenes with forskolin-like structure. These compounds have not 
been previously studied on AChE inhibition due to their low quantity, but were isolated in higher 
yields from PO acetone extract, as previously described elsewhere (Rijo et al., 2005). Also, it 
is known that they activate adenylate cyclase in cooperation with a wide range of 
neurotransmitters (Bone and Mills, 2013), what could justify their further studies.  
Regarding P. porcatus, there is only one phytochemical study providing information on the 
main isolated compound from the acetone extract (Maria Fátima Simões, 2010), namely 
(13S,15S)-6β,7α,12α,19-tetrahydroxy-13β,16-cyclo-8-abietene-11,14-dione (6) as shown in 
Table 2. On the other hand, P. prostratus  simply has literature report on ethnomedical uses 
(Lukhoba et al., 2006). Therefore, more phytochemical studies for these two Plectranthus spp. 
are necessary to identify the causative agents for the registered mild AChE inhibition of 
Plectranthus spp. organic extracts. 
III.3.2 Plectranthus spp. extracts and isolated compounds in tyrosinase 
inhibition in vitro 
In the in vitro anti-tyrosinase assay, the enzymatic activity was evaluated by using L-
tyrosine as substrate, and detecting the produced chromophore (L-DOPA) at 450 nm 
(Yamauchi et al., 2011).  
The data from this in vitro assay represented as the inhibition percentage of tyrosinase, 
calculated with the equation 3b) at section II.6.2, in comparison with the enzymatic activity of 
the negative control (ΔAbs450nm/min).  
According to the results expressed in Figure 11, methanol (25-66%) and acetone (27-68%) 
extracts had the highest tyrosinase inhibition (p<0.05). 
This is the first report on the activity of the Plectranthus spp. organic extracts over 
tyrosinase activity (14.73% to 75.72%), and the results are very promising when compared 
with 92.87 ± 7.28% inhibition held by kojic acid. For P. grandidentatus (PG), the acetone extract 
caused 67.96 ± 3.55% of tyrosinase inhibition, P. ecklonii (PE) methanol extract showed 65.95 
± 3.42%, and P. saccatus (PS) acetone held 56.42 ± 5.68% of anti-tyrosinase activity.  
In fact, (PE) and (PG) had shown the highest anti-tyrosinase activity in vitro, and these 
were also the plants that showed increased antioxidant activity. These results could be 
possibly explained by the abietane diterpenes, mainly present in organic extracts of these two 
plants (Rijo et al., 2012; Rosa et al., 2015). 
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Pursuing a more extensive comprehension of the agents causing tyrosinase inhibition, the 
aqueous extracts obtained from Plectranthus spp. plants, were additionally tested, and the 
results are expressed in Figure 12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In contrast with the results on Figure 11, the aqueous extracts on the represented Figure 
12 had a less effect on tyrosinase (p>0.05) thus lower inhibitory percentages were obtained, 
except for P. porcatus (p<0.0001). The aqueous extract of P. porcatus (PP) was able to inhibit 
tyrosinase by 65.04 ± 8.67%, and in comparison, with kojic acid (92.87 ± 7.28%) this is a very 
curious result.  
Actually, PP aqueous extracts obtained with microwave extraction have been previously 
evaluated by HPLC profile, concerning polyphenols quantification (Rijo et al., 2014a). From 
those studies, it is known that PP aqueous extracts have some amounts of rosmarinic and 
caffeic acids, but it was PE and PS that were reported with the highest polyphenol content 
(Rijo et al., 2014a). Therefore it can only be suggested that the extract activity was probably 
due to a synergistic effect of the present compounds. 
 
 
 
Figure 11 In vitro enzymatic assay on tyrosinase inhibition of Plectranthus spp. organic extracts. The assay uses 
L-tyrosine as substrate and detects the production of L-DOPA. Twenty-two organic extracts were tested at 50 
µg/mL, in triplicate, for their ability to inhibit tyrosinase. The results are presented as means percentage values, 
considering the absorbance of kojic acid as the positive control. Data are expressed as the mean ± SD (n=3) 
*p<0.05 **p<0.005 ***p<0.0001 vs negative control (DMSO 0.5% (v/v) in PBS buffer). Values were determined by 
one-way ANOVA followed by Tukey HSD comparison test. 
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To better understand the extracts obtained results, one additional assay was performed to 
evaluate which natural products present in the organic and aqueous extracts, could be 
responsible for the exhibited anti-tyrosinase activity. For this reason, previously isolated 
compounds from both the organic and aqueous extracts were tested, for their ability to inhibit 
tyrosinase in vitro. The results are shown in Figure 13. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 In vitro enzymatic assay on tyrosinase inhibition of Plectranthus spp. isolated compounds. The assay 
uses L-tyrosine as substrate and detects the production of L-DOPA. Nine compounds were tested at 50 µg/mL, in 
triplicate, for their ability to inhibit tyrosinase. Rosmarinic (12) and chlorogenic (11) acids are mostly isolated from 
aqueous extracts, and the remaining (1-7) are obtained from organic extracts. The results are presented as means 
percentage values, considering the absorbance of kojic acid as the positive control. Data are expressed as the 
mean ± SD (n=3) **p<0.005 ***p<0.0001 vs negative control (PBS buffer, and DMSO 0.5% (v/v) in PBS buffer). 
Values were determined by one-way ANOVA followed by Tukey HSD comparison test. Parv D (4); Roy (1); Cyclo-
abietane (6); Plec C (7); Halimane (5); DeHRoy (3); DiHRoy (2). 
Kojic acid: Positive 
control (IC
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Figure 12 In vitro enzymatic assay on tyrosinase inhibition of Plectranthus spp. aqueous extracts. The assay uses 
L-tyrosine as substrate and detects the production of L-DOPA. Seven aqueous extracts were tested at 50 µg/mL, 
in triplicate, for their ability to inhibit tyrosinase. The results are presented as means percentage values, considering 
the absorbance of kojic acid as the positive control. Data are expressed as the mean ± SD (n=3) ns: not significant 
***p<0.0001 vs negative control (PBS buffer). Values were determined by one-way ANOVA followed by Tukey 
HSD comparison test. 
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The results of the isolated compounds on tyrosinase activity (Figure 13), confirm some of 
the the high inhibition values previously found for the extracts. Notably, the abietane diterpenes 
(1), (3), and (4) present in PG, PM, and PE (main organic extracts) seem to be highly active 
against tyrosinase activity in more than 46% up to 75%.  
Moreover, it is possible to better understand the effect of PP aqueous extract, according to 
the result of compound (6) holding 43.97 ± 1.34% of tyrosinase inhibition, although, this is a 
compound mainly isolated from the acetone extract of PP that showed low tyrosinase inhibition 
in Figure 12 (28.81 ± 3.41, p>0.05). It is possible though, that compound (6) can be present in 
the extract, since the microwave aqueous extraction has a higher efficiency in recovering 
bioactive compounds (Rijo et al., 2014c). Additionally, rosmarinic (12) and chlorogenic acids 
(11) were able to inhibit tyrosinase by 47.87 ± 1.41%, and 40.39 ± 0.74%, respectively. 
Knowing that these compounds are not present in high amounts in PP aqueous extracts, it can 
only be suggested that the extract activity was probably due to the abietane compound, cyclo-
abietane (6). 
Overall, these results suggest that Plectranthus spp. natural product (polyphenols and 
abietane diterpenes) are notably able to inhibit tyrosinase almost as efficient as positive control 
kojic acid.  
The mechanisms of inhibition were not studied, nor the type of inhibition exerted. The most 
potent tyrosinase inhibitors, such as kojic acid, act in the enzyme active site through metal 
chelation (Chen et al., 2015), thus the catalytic activity is significantly impaired. Likewise, 
hydroquinones and phenols (that are part of the chemical structure of abietane diterpenes, 
rosmarinic acid, and chlorogenic acid), have been recognized for their chelating ability (Chen 
et al., 2015), which can probably explain their elevated anti-tyrosinase activity. Actually, due 
to the presence of polyphenolic acids compounds such as chlorogenic acid and quercetin, 
other plants have been used for the treatment of skin depigmentation (Ghimeray et al., 2015). 
Therefore, it is possible to suggest that Plectranthus spp. natural products could be useful in 
a synergistic use for both antioxidant and anti-pigmentation skin treatment.  
III.3.3 Plectranthus spp. extracts and isolated compounds in collagenase 
inhibition in vitro 
The in vitro assay to examine collagenase (ChC) activity, obtained from Clostridium 
histolyticum, was performed using FALGPA as substrate.  
Several studies have reported the catalytic activity of collagenase in collagen breakdown, 
leading to skin damage and wrinkles (Ghimeray et al., 2015; Thring et al., 2009; Wahab et al., 
2014). In this thesis, the ChC activity was measured by the decrease in absorbance of 
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FALGPA hydrolysis, and the relative inhibition was calculated according to equation 4b) 
described in section II.6.3. 
The results expressed in Figure 14 represent the enzymatic assay, performed with twenty-
one organic extracts from Plectranthus spp., that showed mild to high ChC inhibition (from 28-
76%, p<0.0001). The plant extract with the highest anti-collagenase activity was P. neochilus 
(PN) methanol extract holding 76.43 ± 2.09%, in comparison with the positive control (EGCG) 
that inhibited ChC by 93.09 ± 5.27%. In addition, the organic extracts of P. madagascariensis 
(PM), P. grandidentatus (PG), and P. ecklonii (PE) were effective at inhibiting ChC in more 
than 60%. 
 
The obtained results on PN organic extracts highly suggest that the anti-ChC activity 
observed, is mainly due to the naturally present pentacyclic triterpenes, particularly α- and β-
amyrin (14), previously reported for ChC inhibition (Ying et al., 1991). On the other hand, it is 
possible to recognize a high inhibition from PE organic extracts, most likely due to the presence 
of other pentacyclic triterpenes such as oleanolic and ursolic acids (16), and/or abietane 
diterpenes (1-4). 
In fact, the compounds (14) and (16) have been widely studied for their ability to inhibit 
both collagenase and elastase, possibly by reversibly binding to the catalytic sites of these 
enzymes (Jung et al., 2014; Tu and Tawata, 2015; Ying et al., 1991).  
Also, naturally present phenolic compounds have been described as collagenase inhibitors 
(Ghimeray et al., 2015). Therefore, the aqueous extracts from Plectranthus spp. plants 
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Figure 14 In vitro enzymatic assay for collagenase inhibition of Plectranthus spp. 
organic extracts. The assay detects the hydrolysis of the synthetic substrate FALGPA. 
Twenty-one extracts were tested at 100 µg/mL, in triplicate, for their ability to inhibit 
collagenase. The results are presented as means percentage values, considering the 
absorbance of EGCG as the positive control. Data are expressed as the mean ± SD 
(n=3) ***p<0.0001 vs negative control (DMSO 0.3% (v/v) in Tricine buffer). Values were 
determined by one-way ANOVA followed by Tukey HSD comparison test. EGCG – 
Epigallocatechin gallate. 
 
EGCG: Positive 
control (IC
50
 0.9 mM) 
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containing the larger amounts of these compounds, were studied for ChC inhibition, and the 
results are displayed in Figure 15.  
In contrast with the organic extracts, the PN aqueous extract was the lowest ChC inhibitor 
with only 24.90 ± 9.37% (p>0.05), against the positive control EGCG holding inhibition of 93.09 
± 5.27%. Even though, the remaining aqueous extracts revealed more promising results, being 
the highest inhibition of 75.59 ± 6.5% from PE aqueous extract.  
 
 
 
 
 
 
 
 
 
 
Indeed, previous studies regarding the polyphenols quantification on Plectranthus spp. 
plants have established that PE aqueous extracts, from microwave extraction, had one of the 
highest content on rosmarinic acid (12) (Rijo et al., 2014a). This study helps to understand the 
increased collagenase inhibition reported here, since many polyphenolic compounds, such as 
catechin and epigallocatechin gallate (EGCG), have been reported to inhibit collagenase 
(Thring et al., 2009). Some suggestions in literature help understand that polyphenols can act 
as Zn2+ chelators, making the ion unavailable for catalytic activity (Jung et al., 2014; Thring et 
al., 2009).  
The results generally showed that most of the Plectranthus extracts seem to exert an 
inhibitory effect on collagenase. To understand which compounds may be responsible for the 
activity shown, one more assay with the isolated compounds was performed, and the results 
are expressed in Figure 16. 
From the obtained results, two isolated compounds with an abietane diterpene structure 
(3) and (4), along with a polyphenol (12), had the highest ability for collagenase inhibition 
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Figure 15 In vitro enzymatic assay for collagenase inhibition of Plectranthus spp. 
aqueous extracts. The assay detects the hydrolysis of the synthetic substrate 
FALGPA. Seven extracts were tested at 100 µg/mL, in triplicate, for their ability to 
inhibit collagenase. The results are presented as means percentage values, 
considering the absorbance of EGCG as the positive control. Data are expressed 
as the mean ± SD (n=3) ns: not significant ***p<0.0001 vs negative control (Tricine 
buffer). Values were determined by one-way ANOVA followed by Tukey HSD 
comparison test. EGCG – Epigallocatechin gallate. 
 
EGCG: Positive 
control (IC
50
 0.9 mM) 
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(p<0.0001). In fact, Parvifloron D (4) was almost as efficient as EGCG (93.09 ± 5.27%), 
retaining ChC activity by 84.64 ± 5.91%. This is the first report on the ChC in vitro inhibition by 
diterpenes with an abietane backbone. 
 
 
 
 
 
 
 
 
 
Different results were obtained for DiHRoy (2) and Roy (1), that only inhibited ChC by 
24.04 ± 3.02% (p<0.005) and 33.45 ± 3.25% (p<0.0001), which are also abietane diterpenes 
but with a royleanone motif, that may be lowering the inhibitory capacity. One possible 
explanation could be taking into consideration that ChC inhibitors mainly act by metal 
chelation. There is one particular feature for Parvifloron D (4) differently apart from the other 
abietane, which is a structure including different donor atoms, resulting in higher metal 
chelation (Rosa et al., 2015).  
Rosmarinic acid (12) inhibited collagenase by 44.78 ± 4.53% (p<0.0001), suggesting 
the presence of other polyphenols such as chlorogenic acid or caffeic acid in the aqueous 
extracts to possibly justify the reported activity of Figure 15. 
Besides metal chelation, polyphenols can be acting through the hydroxyl and/or 
benzene group, forming hydrogen bonds, or through hydrophobic interaction with ChC 
functional groups (Wahab et al., 2014). Thus, Plectranthus spp. plants seem to be highly 
promising for developing potential cosmetic agents against skin ageing induced by increased 
collagenase activity. 
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Figure 16 In vitro enzymatic assay for collagenase inhibition of Plectranthus spp. isolated compounds. The assay 
detects the hydrolysis of the synthetic substrate FALGPA. Eight compounds were tested at 100 µg/mL, in triplicate, 
for their ability to inhibit collagenase. The results are presented as means percentage values, considering the 
absorbance of EGCG as the positive control. Data are expressed as the mean ± SD (n=3) *p<0.05 **p<0.005 
***p<0.0001 vs negative control (Tricine buffer, and DMSO 0.3% (v/v) in Tricine buffer). Values were determined 
by one-way ANOVA followed by Tukey HSD comparison test. EGCG – Epigallocatechin gallate. Rosmarinic acid 
(12) is mostly isolated from aqueous extracts, and the remaining (1-7) are obtained from organic extracts. 
Parvifloron D (4); DeHRoy (3); Halimane (5); Roy (1); Cyclo-abietane (6); DiHRoy (2); Plec C (7). 
EGCG: Positive 
control (IC
50
 0.9 mM) 
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III.3.4 Plectranthus spp. extracts and isolated compounds in elastase 
inhibition in vitro 
Besides collagen, elastin also plays an important role in the dermis matrix. Because ROS 
can induce the expression of proteinases, their activation (e.g., matrix metalloproteinases and 
serine proteases) may be involved in the lack of skin elasticity (Wahab et al., 2014). It has 
been shown, that damage to the elastic fiber network in the skin of hairless mice, was 
responsible for wrinkling of UVB-exposed skin (Lee et al., 2001).  
Since elastin degradation leads to line and wrinkle formations in the skin, agents that inhibit 
elastase activity are ideal candidates for the treatment or prevention of skin aging (Lee et al., 
2001; Wahab et al., 2014). 
In this assay, elastase from porcine pancreas was used with the synthetic substrate N-
sucynil-Ala-Ala-Ala-pNA (SANA), knowing that 1 U enzyme converts 1 µmol of SANA per 
minute with Tris-HCl buffer (pH 8.0) at 25ºC. The assay detected at 405 nm the increasing of 
absorbance, by the hydrolisis of SANA, producing p-nitroaniline. 
Ursolic acid was used as a positive control, since it is known for more that two decades, 
that several pentacyclic triterpenoid metabolites of plant origin are great elastase inhibitors. 
Ursolic acid, the most potent of these compounds, was reported to have an inhibition constant 
of 4-6 µM (Ying et al., 1991).  
Results for the enzymatic assay regarding the organic extracts from Plectranthus spp. 
plants are expressed in Figure 17. In contrast to what has been observed in the previous 
enzymatic assays developed in this thesis, the organic extracts were not good elastase 
inhibitors, since the maximum inhibition obtained was 42.84 ± 4.18% from P. grandidentatus 
ethyl acetate.  
Overall the extracts inhibited elastase in about 30% (p<0.0001), with exception for P. 
madagascariensis (PM) organic extracts that held no elastase inhibition, as well as P. 
grandidentatus (PG) acetone extract (p>0.05). The positive control used in this assay was 
ursolic acid inhibited elastase by 69.85 ± 3.65%.  
Additionally, P. neochilus (PN) and P. ecklonii (PE) extracts also revealed mild elastase 
inhibition, possibly due to the presence of different types of triterpenes such as α- and β-amyrin 
(14), oleanolic acid and ursolic acid (16). 
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Moreover, since previous studies have suggested that polyphenolic compounds have anti-
elastase activity by the interaction of the hydroxyl groups with the elastase domain (Lee et al., 
2001), the aqueous extracts were tested and the results are shown in Figure 18.  
The results on Figure 18 revealed that the aqueous extracts were not effective upon 
elastase activity (p>0.05), being PG aqueous extract the only one holding 23.82 ± 9.99% of 
anti-elastase activity (p<0.0001). This result was possibly due to different and improved 
synergy of the polyphenols present in PG aqueous extract, in comparison with the remaining 
aqueous extracts (Rijo et al., 2014a).  
 
 
 
 
 
 
 
 
 
 
Figure 18 In vitro enzymatic assay for elastase inhibition of Plectranthus spp. aqueous extracts. The assay was 
performed using SANA as substrate, and detects the formation of p-nitroaniline at 405 nm. Seven aqueous extracts 
were tested at 100 µg/mL, in triplicate, for their ability to inhibit elastase. The results are presented as means 
percentage values, considering the absorbance of ursolic acid as the positive control. Data are expressed as the 
mean ± SD (n=3) ns: not significant ***p<0.0001 vs negative control (Tris-HCl buffer). Values were determined by 
one-way ANOVA followed by Tukey HSD comparison test.  
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Figure 17 In vitro enzymatic assay for elastase inhibition of Plectranthus spp. organic extracts. The assay was 
performed using SANA as substrate, and detects the formation of p-nitroaniline at 405 nm. Twenty-two organic 
extracts were tested at 100 µg/mL, in triplicate, for their ability to inhibit elastase. The results are presented as 
means percentage values, considering the absorbance of ursolic acid as the positive control. Data are expressed 
as the mean ± SD (n=3) ns: not significant ***p<0.0001 vs negative control (DMSO 1% (v/v) in Tris-HCl buffer). 
Values were determined by one-way ANOVA followed by Tukey HSD comparison test.  
 
Ursolic acid: Positive 
control (IC
50
 31 µg/mL)  
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The isolated compounds were further assessed for their ability to inhibit elastase, and in 
contrast to what was observed in the extracts (Figures 17 and 18), the tested compounds 
highly inhibited elastase. The results are expressed in Figure 19.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In accordance with the positive control, ursolic acid holding 69.85 ± 3.65% of elastase 
inhibition, the 1:4 mixture of oleanolic:ursolic acid also had an high anti-elastase activity with 
63.42 ± 2.56% (p<0.0001). These preliminary results strengthen the literature reports obtained 
so far on the pentacyclic triterpenes interaction on elastase, possibly involving different 
subsites (Lee et al., 2001). In contrast, other compounds with pentacyclic triterpene similar to 
that ursolic acid like α- and β-amyrin (14), was anticipated to have higher anti-elastase activity 
(p>0.05), according to previous studies (Thring et al., 2009). This is the first report on elastase 
inhibition of ursolic and oleanolic acids, isolated from Plectranthus spp. plants.  
Following the triterpenes, royleanone-like diterpenes were also very effective in 
elastase inhibition (p<0.0001). These compounds such as Parvifloron D (4) 52.83 ± 3.76%, 
DiHRoy (2) 39.16 ± 5.18%, and DeHRoy (3) 38.33 ± 4.40%, have high elastase inhibitory 
activity. These in vitro inhibition assays suggest that the Plectranthus spp. plants with agents 
acting in elastase inhibition, are possible candidates for the treatment or prevention of skin 
photoaging. 
The obtained preliminary results of the three skin-related enzymatic inhibitions in vitro 
are displayed in Table 7, suggesting that Plectranthus spp. natural products are promising 
agents for future formulations regarding hyper-pigmentation, wrinkle, and sagging of the skin.  
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Figure 19 In vitro enzymatic assay for elastase inhibition of Plectranthus spp. isolated compounds. The assay 
was performed using SANA as substrate, and detects the formation of p-nitroaniline at 405 nm. Eleven 
compounds were tested at 100 µg/mL, in triplicate, for their ability to inhibit elastase. The results are presented 
as means percentage values, considering the absorbance of ursolic acid as the positive control. Data are 
expressed as the mean ± SD (n=3) ns: not significant **p<0.005 ***p<0.0001 vs negative control (DMSO 1% (v/v) 
in Tris-HCl buffer). Values were determined by one-way ANOVA followed by Tukey HSD comparison test. 
Urso:Oleano (16); Parvifloron D (4); DiHRoy (2); DeHRoy (3); Plec C (7); Roy (1); Halimane (5); Cyclo-abietane 
(6); α,β-amyrin (14); β-sito:stigma (15); Forskolins (13). 
Ursolic acid: 
Positive control 
(IC
50
 31 µg/mL)  
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Table 7 Results comparison for in vitro inhibition of tyrosinase, elastase, and collagenase skin-related enzymes 
screening, of isolated compounds from Plectranthus spp. The results are expressed as enzymatic inhibition ± 
standard deviation (SD). 
 
 Enzymatic Inhibition ± SD (%) 
Isolated compounds  Anti-Tyrosinase ** Anti-Elastase* Anti-Collagenase* 
Roy (1) 46.62 ± 4.74 29.26 ± 2.75 
33.45 ± 3.25 
DiHRoy (2) 14.73 ± 2.02 39.16 ± 5.18 
24.04 ± 3.02 
DeHRoy (3) 75.72 ± 3.61 
38.33 ± 4.40 60.63 ± 9.68 
Parvifloron D (4) 72.73 ± 5.63 
52.83 ± 3.76 
84.64 ± 5.91 
Halimane (5) 38.26 ± 0.63 
27.27 ± 1.41 
41.50 ± 4.87 
Cyclo-abietane (6) 43.97 ± 1.34 
21.19 ± 2.09 24.63 ± 9.18 
Plectrornatine C (7) 41.29 ± 2.71 
33.34 ± 3.30 16.70 ± 1.87 
Chlorogenic acid (11) 40.39 ± 0.73 
NT NT 
Rosmarinic acid (12) 47.97 ± 1.41 NT 44.78 ± 4.53 
Forskolins (13) NT 6.15 ± 3.49 NT 
α,β-amyrin (14) NT 15.83 ± 1.99 NT 
β-sitosterol:stigmasterol 
(15) 
NT NT NT 
Oleanolic:Ursolic acid (16) NT 63.45 ± 2.56 NT 
Positive Control 92.87 ± 7.28 / KOJ 69.85 ± 3.65 / URS 93.09 ± 5.27 / EGCG 
 
NT – Not Tested; KOJ – Kojic acid; URS – Ursolic acid; EGCG – Epigallocatechin gallate 
*Samples tested at 100 µg/mL; **Samples tested at 50 µg/mL 
Roy(1)– 7α-acetoxy-6β-hydroxyroyleanone; DiHRoy(2)– 6β,7α-dihydroxyroyleanone; DeHRoy(3)– 6,7-
dehydroroyleanone; Halimane(5)– 11R*-acetoxy-halima-5,13E-dien-15-oic acid; Cyclo-abietane(6)– (13S,15R)-
6β,7α,12α,19-tetrahydroxy-13β,16-cyclo-8-abietane-11,14-dione; Plectrornatine C(7)– 1α,6β-diacetoxy-8α,13R*-
epoxy-14-labden-11-one; Forskolins(13)– 1,6-di-O-acetylforskolin+1,6-di-O-acetyl-9-deoxyforskolin (mixture 1:1). 
III.4 Anti-inflammatory study on isolated compounds by NO 
quantification with Griess assay 
Plectranthus spp. isolated compounds were tested for their ability to decrease nitric oxide 
(NO) production, after induced inflammation in macrophage RAW 264.7 cell line, using 
lipopolysaccharide (LPS). After cytotoxic screening with 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay (see section II.7.1), eight of the total ten compounds 
proceeded to anti-inflammatory assay in vitro (section II.7.2).  
III.4.1 MTT cytotoxicity assay of isolated compounds on RAW 264.7 cells 
In this study, the cytotoxicity of the tested isolated compounds was evaluated. Preceding 
the in vitro anti-inflammatory activity, the cell viability assay was performed with the compounds 
(1), (3-4), (6-8), and (12-15), at several concentrations (100, 50, 25, 12.5, 10, 5, 2.5 and 1 µM), 
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to assess the capability of RAW 264.7 macrophage cells to reduce 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT). This reaction detected the formazan crystals 
produced by living cells, at 590 nm after dissolution in DMSO (Rodrigues et al., 2014, 2016). 
The results of the MTT assay are displayed in Appendix Figure I.1. These results show the 
cell viability after 24-hours treatment with the compounds at several concentrations.  
The graphics depict, in black bars, the concentration at which cell viability was higher than 
80%, in comparison with the negative control DMSO 0.5% (v/v) in RPMI medium as 100% of 
cellular viability.  
From Figure I.1 resulted that at the highest concentration of 100 µM, rosmarinic acid (12) 
was the single compound holding 79.49 ± 4.31 % of cell viability, followed by, halimane (5), 
Plectrornatine C (7), cyclo-abietane (6), β-sitosterol:stigmasterol (15), and α,-β-amyrin (14), 
which were nontoxic at 50 µM.  
Regarding DeHRoy (3) and forskolin type compound (13), they only held up to 86.12 ± 
1.30% and 94.27 ± 3.89% of respective cell viability, in concentrations lower than 10 µM, and 
12.5 µM, respectively.  
Finally, Parvifloron D (4) and Roy (1) exhibited low cell viability, being only safe at 1 µM 
(87.18 ± 11.70%), and 5 µM (80.15 ± 6.50%), respectively.  
Due to some uncertainty of percentage values, observed by the elevated standard 
deviations of these two results, compounds (1) and (4) did not proceed to further anti-
inflammatory testing.  
This is the first report of cytotoxicity values for RAW 264.7 cells with the isolated 
compounds from Plectranthus spp., and the preliminary IC50 values are expressed in Table 8, 
in comparison with the positive control epimuqubilin A (Cheenpracha et al., 2010).  
The lowest IC50 values belong to Parvifloron D (4) with 7.41 µM, and to Roy (1) with 9.40 
µM. In comparison with the compound with lowest viability, DeHRoy (3) (IC50 19.2 µM), 
compounds (1) and (4) are almost two-fold more toxic. Therefore, these two compounds did 
not continue to the anti-inflammatory assay, due to their elevated toxicity.  
The remaining eight compounds proceeded to in vitro evaluation of nitric oxide (NO) 
production by stimulated RAW 264.7 cells. 
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Table 8 Cytotoxicity evaluated by the MTT assay for the isolated compounds. The results represent the IC50 
values (µM) of isolated compounds tested on RAW 264.7 macrophage cell line. Data in bold represent the two most 
cytotoxic compounds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Epimuqubulin A was considered as the positive control at the tested concentration of 51µM. 
 
III.4.2 NO production upon inflammation on RAW 264.7 cells after 
treatment with non-cytotoxic isolated compounds 
During inflammation, macrophages play an essential role in the release of pro-inflammatory 
factors such as NO, ROS, NF-κB, iNOS, and cycloxygenase-2 (COX-2), and pro-inflammatory 
cytokines like, interleukin-1β (IL-1β), interleukin-6 (IL-6), and TNF-α (Lee et al., 2013). 
The macrophages RAW 264.7 cell line are chosen for many anti-inflammatory in vitro 
studies, since they express the TLR4 receptor that through incubation with lipopolysaccharide 
(LPS), can trigger production the of some inflammatory mediators (Balaji and Ramanathan, 
2014), such as NO. In this context, NO production was measured in LPS-stimulated RAW 
264.7 macrophage cells, after treatment with nontoxic concentrations of eight isolated 
compounds. Therefore, a reduction in NO production after treatment with the compounds 
would be indicative of the potential to attenuate an inflammatory response. 
In this study, the isolated compounds were tested at the maximum concentration at which 
they were non-cytotoxic, defined in section III.5.1. The results on NO production are expressed 
in Figure 20. The results express NO quantification (µM) of LPS-stimulated RAW 264.7 
macrophages, after incubation with compounds (at nontoxic concentrations), in comparison 
with the negative controls, DMSO 0.5% (v/v) in RPMI medium (without phenol red) without 
LPS, and DMSO 0.5% (v/v) supplemented with LPS, and the positive control, a known inhibitor 
of NO production upon inflammation, L-NAME (Wang and Leigh, 2006). 
Samples IC50 (µM) 
Epimuqubilin A* 37.1 
Halimane (5) 47.8  
Parvifloron D (4) 7.41 
Plectrornatine C (7) 64.8 
DeHRoy (3) 19.2 
Cyclo-abietene (6) >100 
Forskolins (13) 43.5 
Roy (1) 9.40  
Rosmarinic Acid (12) >100 
β-sitosterol:stigmasterol (15) >100 
α-, β-amyrin (14) >100 
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The nitrite quantification was evaluated with the Griess reaction and measured at 540 
nm, using a calibration curve obtained with several solutions of known concentrations (1.6, 
3.1, 6.25, 12.5, 25, 50, and 100 µM), using sodium nitrite used as standard.  
With this assay it was possible to observe that the isolated compounds were not able to 
reduce the NO production after LPS-stimulated inflammation (p>0.05), in comparison with the 
positive control L-NAME.  
The inflammation process generated NO at 15.70 ± 0.99 µM (negative control with DMSO 
0.5% (v/v) supplemented with LPS), and the treatment with compounds maintained this NO 
quantities around 16.05 µM, and 20.16 µM. In truth it was observed a slight increase in NO 
production after treatment with some compounds, suggesting an intensification of the observed 
inflammation. 
The obtained results in Figure 20 were far from the expected, since several natural 
products from Plectranthus plants have been reported for their anti-inflammatory activity (Chiu 
et al., 2012; Lukhoba et al., 2006; Rijo et al., 2013a). Forskolin-like compounds are specially 
notorious for their anti-inflammatory properties (Klatz and Goldman, 2003; Rijo et al., 2005). In 
addition, phytosterols such as β-sitosterol and stigmasterol, triterpenes (α- and β-amyrins, 
oleanolic and ursolic acids), here obtained from P. ecklonii, and polyphenols, have also been 
validated for anti-inflammatory purposes (Ghimeray et al., 2015; Pereira et al., 2015; Sergent 
et al., 2010).  
Besides triterpenes and forskolins-like compounds, it was also expected that the 
polyphenolic compound tested, rosmarinic acid would demonstrate some anti-inflammatory 
L-NAME: Positive 
control (IC
50
 29 
µg/mL)  
Figure 20 Anti-inflammatory assay in vitro, on macrophage cells RAW 264.7. The inflammation process was 
induced by adding LPS to the cells medium during 24 hours, together with nontoxic compounds for treatment. The 
medium was mixed with the Griess reagent for nitrite quantification at 540 nm. The grey bar represents the 
negative control (DMSO 0.5% (v/v) in RPMI without phenol red) before adding LPS, and the black bar the negative 
control after adding LPS. The results are presented as means concentration values, considering the absorbance 
of L-NAME at 29 µg/mL, as the positive control. Data are expressed as the mean ± SD (n=6) ns: not significant, 
***p<0.0001 vs negative controls (DMSO 0.5% (v/v) in RPMI without phenol red, with and without LPS). Values 
were determined by one-way ANOVA followed by Tukey HSD comparison test. DeHRoy (3); Plec C (7); Halimane 
(5); Cyclo-abietane (6); α,β-amyrin (14); β-sito:stigma (15); Forskolins (13); Rosmarinic acid (12).  
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outcome. The polyphenolic compounds are considered to possess anti-inflammatory 
properties and have been proposed as an alternative natural approach to prevent or treat 
chronic inflammatory diseases (Sergent et al., 2010).  
However, this is the first report on the anti-inflammatory effect by NO production tested in 
vitro, with macrophage cells, of such compounds isolated from Plectranthus spp. plants. 
Mainly, the results suggest that the compounds do not exert an anti-inflammatory response 
through the NO mechanism, although it does not mean that they do not possess anti-
inflammatory activity at all. For sustainable conclusions, it would be necessary to further 
evaluate their effect on other inflammation mediators, for instance, in COX-2. This could be 
achieved for instance, by COX-2 enzymatic inhibition assay. The COX-2 enzymatic inhibition 
assay was attempted to be performed in this project, and the details are in Appendix II, 
although the protocol establishment is still under study. 
III.5 Mycobacterium tuberculosis H37Rv growth with CFU assay 
For the Mycobacterium tuberculosis H37Rv growth assay, peripheral blood 
mononuclear cells (PBMC) were isolated from random healthy volunteers, at the blood bank 
of University “La Sapienza” in Italy (Section II.8.1). The obtained monocytes from the LS 
column, were plated and incubated at 37ºC in a humidified with 5% CO2 atmosphere, during 4 
days for cell adhesion and differentiation. 
The LDH cytotoxicity test was performed at the minimum inhibitory concentration (MIC), 
for each compound in Mycobacterium tuberculosis (Mtb), (Section II.8.2) proceeded by CFU 
analysis at 10-3 dilution after 13 days of infection and treatment (Section II.8.3). 
III.5.1 LDH release (cytotoxicity assay) on macrophages derived from 
PBMC 
The cytotoxicity assay measured the release of cytosolic lactate dehydrogenase (LDH) 
upon cell lysis. The enzyme LDH released in the supernatant, and by conversion of the 
tetrazolium salt into red formazan, was detected at 490 nm proportional to cell lysis. 
This experiment was performed using previously reported minimum inhibitory 
concentration (MIC) for M. tuberculosis, described in Table 4 (Rijo et al., 2010, 2011). The 
experiment was performed with the CytoTox® 96 Non-Radioactive Cytotoxicity Assay kit from 
Promega. Staurosporine (STS) isolated from Streptomyces staurospores, is a protein kinase 
inhibitor that induces DNA fragmentation and apoptosis. Therefore, besides LDH 100% 
release, STS was also used as a positive control for the cytotoxicity assay, and was tested at 
2 µM. 
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The results expressed in Figure 21, assisted the understanding on whether the compounds 
were cytotoxic for macrophages, so that false positives would be avoided in further studies. 
Isoniazid (INH) and ethambutol (ETAN), the positive controls for Mtb infection, were also 
tested for their cytotoxicity to guarantee that there not toxic at a concentration 10-fold their MIC 
values (1 µg/mL, and 40 µg/mL, respectively). 
From these results, it was observed that the positive control STS, resulted in macrophage 
cytotoxicity of 21.86% (p<0.0001). From the tested isolated compounds, Parvifloron D (4) was 
considered as a much more powerful cytotoxic agent that caused 52.46% of macrophage cell 
death, thus it did not proceed to Mtb growth assays (p<0.0001). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The remaining samples, including ETAN and INH, did not significantly revealed toxicity 
for macrophage cells (p>0.05), as they were similar to the negative control, the untreated cells 
(UNT). Thus, with exception for compound (4), all samples were selected for the subsequent 
test of colony-forming units. 
III.5.2 Colony-forming units assay for Mycobacterium tuberculosis H37Rv 
growth 
Quantitative analysis of Mycobacterium tuberculosis (Mtb) growth via the determination 
of colony forming units (CFUs), from serially diluted suspensions, was the method of choice, 
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Figure 21 Cytotoxicity assay performed by LDH method of the Plectranthus isolated compounds. The negative 
control were untreated cells (UNT), and two positive controls were used, 100% of LDH release (LDH positive control 
from kit), and staurosporine (STS 2 µM). The positive control for Mtb infection isoniazid (INH 1 µg/mL), and 
ethambutol (ETAN 40 µg/mL) were also tested. The absorbance measurement was performed 48-hours after 
treatment  with controls and drugs used at  MIC (25 µg/mL),  with the exception of  Parvifloron D (4)  whose MIC 
was 15.6 µg/mL. All values represent mean ± SD (n=3). Values were determined by one-way ANOVA followed by 
Tukey HSD comparison test, ns: not significant, ***p<0.0001. 
Acetoxy-Royleanone (Roy, 1); Dehydro-Royleanone (DeHRoy, 3); Dihydro-Royleanone (DiHRoy, 2); Parvifloron D 
(4); Cyclo-abietane (6); Plectrornatine C (7); Halimane (5); Halimane ester (8); Halimane butyryl (9); Halimane diol 
(10).  
Staurosporine 
IC50=250 nM 
 
 
59 
 
since this was an the initial evaluation of compounds for anti-tubercular activity (Cai et al., 
2013). 
After attaining the cytotoxicity results, monocytes were again obtained from PBMC 
isolation, and incubated at 37ºC in a humidified with 5% CO2 atmosphere, during 4 days for 
cell adhesion and differentiation. After this time, the cells were infected with Mtb, in a biosafety 
level 3 laboratory. Due to the time consuming assay, and the timeline of this thesis, it was only 
possible to evaluate the effects on Mtb growth of compounds (5) and (7-10).  
Treatment with the compounds (5) and (7-10) started 2 hours after infection and was kept 
until the end of the experiment. The concentrations tested were according to the MIC values 
(25 µg/mL), described in Table 4. Viable bacteria were evaluated after 13 days of incubation 
at the 10-3 dilution. Values are expressed in Figure 22 as the logarithm of CFU/mL. The 
normalized preliminary results, expressed in Figure 22, of colony-forming units counts (dilution 
10-3) have shown very interesting results, especially regarding the compound a derivative of 
halimane (9), available in the laboratory. The high efficacy in decreasing Mtb growth from 
compound (9) resulted in 2.1×105 CFU/mL, in comparison with the positive controls, 
ethambutol (2.0×105 CFU/mL) and isoniazid (1.2×105 CFU/mL), two known drugs used for Mtb 
infection treatment. The remaining compounds revealed approximately the same CFU counts 
as the non-treated control (6.0×105 CFU/mL).   
Regarding the halimane diterpenes differences, compound (9) was obtained by hemi-
synthesis from compound (5), performing a reduction with lithium aluminum hydride. This 
difference can be the reason for some enantiomeric derivatives having higher affinity than TPP 
to the diterpene synthase encoded by Rv3378c (Chan et al., 2014; Hoshino et al., 2011). From 
all the compounds tested, (9) could be more suitable to interact with the binding site, thus 
inhibiting the production of tuberculosinols, ultimately avoiding the phagocytosis suppression 
(Layre et al., 2014; Mann and Peters, 2012), and leading to a decrease in CFU. 
As future studies, is essential to better understand how compound (9) may be acting upon 
Mtb growth. Western blot and immunofluorescence methods can evaluate whether there is 
inhibition of the phagolysosome biogenesis, by arresting phagosome maturation. 
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In the Western blot assay, it is possible to study two autophagy markers, microtubule-
associated protein 1 light chain 3 (LC3), that is translocated from the cytosol to the auto-
phagosome membrane, and the autophagy adaptor protein p62/SQSTM1 (p62), that works in 
the initiation, and progression of auto-phagosome formation by mediating ubiquitination 
(Komatsu and Ichimura, 2010; Seto et al., 2013). For immunofluorescence assay, it would be 
necessary that macrophages were infected and treated with a possible lysosome inhibitor (for 
phagosome maturation with lysosome), and with rapamycin which is a known autophagy 
inducer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22 In vitro evaluation of the effect of isolated compounds on Mtb viability, on infected macrophages derived 
from PBMC, using the colony-forming units assay. Macrophages were treated with the positive controls, in a 
concentration 10-fold the MIC, isoniazid (INH) at 1 µg/mL, and ethambutol (ETAN) at 40 µg/mL, and isolated 
compounds at the MIC values (25 µg/mL), 2-hours after infection. In this assay Plectranthus isolated compounds (5, 
7-10) were tested.  The treatment was kept at 37ºC, and plated at serial dilutions of the bacterial suspensions on 
7H10 agar plates. Viable bacteria were evaluated at 10-3 dilution, after 13 days of colony growth. The negative 
control were untreated (UNT) cells. All values represent mean ± SD (n=3). Values were determined by one-way 
ANOVA followed by Tukey HSD comparison test, ns: not significant, *p<0.05. Plectrornatine C (7); Halimane (5); 
Halimane ester (8); Halimane butyryl (9); Halimane diol (10).  
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IV. CONCLUSIONS AND FUTURE PERSPECTIVES 
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The presented thesis performed a screening of biological activities of eight Plectranthus 
spp. plants namely, P. grandidentatus, P. ecklonii, P. ornatus, P. madagascariensis, P. 
porcatus, P. neochilus, P. prostratus and P. saccatus. Previous isolated secondary metabolites 
and prepared extracts were subjected to several different assays concerning their antioxidant 
activity, in vitro inhibition of skin-related enzymes, reduction of NO concentration for anti-
inflammatory assessment, and Mycobacterium tuberculosis H37Rv survival decrease. 
All ultrasound assisted and microwave extracts (twenty-one organic extracts - 
methanol, ethyl acetate and acetone - and seven aqueous extracts) from each of the 
Plectranthus spp. were successfully obtained and assessed in the biological tests. 
ROS can initiate complex molecular pathways for melanogenesis (pathway of 
tyrosinase), and activate extracellular matrix metalloproteases such as collagenase and 
elastase. Therefore, this is a primary evaluation of potential agents for a synergistic treatment 
(antioxidant and skin-related enzymatic inhibition) of skin disorders, regarding ageing, sagging, 
and hyper-pigmentation of the skin. The antioxidant activity by the DPPH radical scavenging 
assay, and in vitro inhibition of skin-related enzymes, namely anti-tyrosinase, -elastase, and -
collagenase assays, enabled to conclude by the preliminary results that P. grandidentatus 
ethyl acetate (62.3 ± 0.43%), P. ecklonii methanol (75.9 ± 1.02%), and P. madagascariensis 
methanol (48.4 ± 1.23%) extracts, generally had the highest values of radical scavenging and 
enzymatic inhibition.  
Interestingly, the isolated compounds mainly present in these plants extracts (abietane 
diterpenes, triterpenes and polyphenols), also revealed increased effects on tyrosinase, 
elastase, and collagenase inhibitions.  
The AChE in vitro enzymatic assay was performed in order to find new inhibitors, due 
to the importance of AChE in the human skin, apart from its extensively known relevance in 
the diagnostic and/or treatment of Alzheimer disease. Although, preliminary results showed 
that the Plectranthus spp. organic extracts were not able to significantly decrease AChE 
activity (less than 17%), in comparison with the positive control tacrine (95.7 ± 2.89%). Even 
though, previous reports have shown a high AChE inhibition on some Plectranthus spp. plants 
aqueous extracts (P. barbatus, P. ecklonii and P. saccatus), due to rosmarinic and caffeic acids 
as major compounds.  
In the anti-tyrosinase enzymatic assay, P. porcatus aqueous extract had the highest 
inhibition percentage (65.04 ± 8.67%), along with the organic extracts, such as P. 
grandidentatus acetone (67.9 ± 3.55%), P. ecklonii methanol (65.5 ±3.42%) and P. saccatus 
acetone (56.5 ± 5.68%). Since P. porcatus aqueous extract, has been reported to have low 
amounts of polyphenolic compounds, and knowing that these compounds are not present in 
high amounts, it could be suggested that the extract activity was probably due to the abietane 
compound, cyclo-abietane (6). 
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The anti-collagenase assay of the tested extracts and compounds, had an inhibition of 
28-76%. P. neochilus methanol extract held the highest result (75.4 ± 2.09%), whereas P. 
ecklonii aqueous extract inhibited ChC by 75.6± 6.5%. For elastase, the samples tested were 
not efficient overall, but the highest inhibitions were obtained from the oleanolic:ursolic acids 
1:4 mixture (63.4 ± 2.56%) and Parvifloron D (52.8 ± 3.76%). 
Regarding the anti-inflammatory assay of the isolated compounds, the ability to 
decrease NO production was measured in LPS-stimulated RAW 264.7 macrophage cells. The 
NO quantification evaluated by the Griess reaction, revealed that the non-cytotoxic compounds 
were not able to reduce the NO production (16-23 µM), after LPS-stimulated inflammation, in 
comparison with the normal NO production from the cells (17.7 ± 0.67 µM) and L-NAME (3.9 
± 0.2 µM). However, according to the references in this work, this is the first report on this 
activity by Plectranthus spp. isolated compounds. Supplementary studies to evaluate other 
inflammation mediators, for instance, COX-2 (by in vitro enzymatic inhibition), could be studied 
to understand which anti-inflammatory mechanisms are (or not) activated. 
The final biological assay evaluated the Mtb H37Rv growth assay, after macrophages 
(derived from PBMC) infection, and treatment with isolated compounds. The first results of 
normalized CFU revealed very interesting results, especially regarding a halimane diterpene 
compound (2.1×105 CFU/mL), obtained by hemi-synthesis. This possible treatment with the 
halimane diterpene, leading to the growth inhibition of the bacteria, could be the cause of the 
observed CFU decrease, in comparison with isoniazid (1.2×105 CFU/mL) and ethambutol 
(2.0×105 CFU/mL). Nonetheless, as a future perspective regarding Mtb survival assays, it 
would be important to better understand the growth mechanisms of action. Western blot and 
immunofluorescence methods, could evaluate whether there is inhibition of the 
phagolysosome biogenesis, by arresting phagosome maturation.  
According to the references of this thesis, this is the first report on seven Plectranthus 
spp. medicinal plants biological activities, with preliminary scientific validations upon their 
known ethnopharmacological uses. Although the recent renewed interest on medicinal plants 
and their biological applications, it is important to improve the studies on Plectranthus spp., to 
scientifically validate their uses, understand their safety, and unravel new bioactive compounds 
with therapeutic potential and specific targets. 
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Appendix I – Cytotoxicity evaluation using the MTT assay: 
Graphical results for the tested compounds concentrations 
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Figure I.1 In vitro evaluation of the compounds cytotoxicity at 
several concentrations (100, 50, 25, 12.5, 10, 5, 2.5, and 1 µM). 
The test was performed using the MTT assay, and the black bars 
represent the concentration at which the compounds were 
nontoxic. Due to the low values obtained by parvifloron D (4) and 
Roy (1), these two compounds did not proceed to inflammatory 
evaluation in vitro. The results were calculated in comparison with 
DMSO 0.5% (v/v) in RPMI medium, as 100% of cell viability. Data 
are expressed as mean percentages ± standard deviation (SD). 
 The test was performed using the MTT assay, and the black bars 
represent the concentration at which the compounds were 
nontoxic. Due to the low values obtained by parvifloron D (4) and 
Roy (1), these two compounds did not proceed to inflammatory 
evaluation in vitro. The results were calculated in comparison with 
DMSO 0.5% (v/v) in RPMI medium, as 100% of cell viability. Data 
are expressed as mean percentages ± standard deviation (SD). 
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Appendix II – Anti-inflammatory assay: Cyclooxygenase-2 
enzymatic inhibition in vitro with TMPD assay 
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Reagents and materials 
N,N,N’,N’-tetramethylphenylenediamine (TMPD) 98%, and hematin 97% were purchased 
from Alfa Aesar. Arachidonic acid 98% was obtained from Cayman Chemical Company. 
Diclofenac sodium 99.4% was acquired from Fagron. Cyclooxygenase-2 (COX-2) ≥70% (SDS-
PAGE), from human recombinant expressed in Sf 21 cells, and 2,6-tert-butyl-4-methylphenol 
(BHT) were purchased from Sigma-Aldrich. 
Enzymatic assay for COX-2 inhibition - Trials 
COX-2 activity can be measured in an assay using arachidonic acid as substrate, and 
TMPD as co-substrate. This works as an artificial electron donor that undergoes co-oxidation 
by PGG2 producing a blue product, detected at 590 nm (Petrovic and Murray, 2010).  
Although this is an indirect method, the oxidation of TMPD has been shown to accurately 
reflect the rate of conversion of arachidonic acid to PGH2 (Petrovic and Murray, 2010). 
The assay was performed several times by optimization of COX-2, hematin, TMPD, and 
arachidonic acid concentrations. The several modifications of concentrations did not improve 
the colorimetric detection of COX-2 activity. From all the attempts, it was not observed a 
change in the assay color in each well, therefore it was not possible to pursue to COX-2 
inhibition evaluation in vitro. 
In general, the colorimetric assay should detect the increase of blue color from the co-
oxidation of TMPD by PGG2, which is proportional to COX-2 activity. Therefore, the velocity 
reaction of control (ΔAbs595nm/min) should be linear, and close to 0.060. 
Diclofenac is usually used as the positive control which holds IC50 value of 0.63 µM (Blanco 
et al., 1999), whereas the negative controls comprise the respective sample solvent, at same 
dilution.  
From the several attempts, it can be suggested that the assay was not established due to 
the spontaneous oxidation of TMPD crystals. The co-substrate was prepared in several 
solutions, including Tris-HCl buffer, ethanol 70% (v/v), absolute ethanol, DMSO, and HCl 1% 
(v/v). None of the trials decreased the apparent initial blue color of TMPD solution. 
 
 
 
 
 
 
 
Figure II.1 Detection of COX-2 peroxidase activity with N,N,N’,N’-tetramethylphenylenediamine (TMPD). The 
artificial electron donor TMPD undergoes co-oxidation by PGG2 to a blue product (oxidized TMPD), that is detected 
at 595 nm. TMPD is a readily oxidizable compound that serves as a reducing co-substrate for heme peroxidases 
(Petrovic and Murray, 2010).  
